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INTRODUCTION
Pseudomonas spp. produce a wide spectrum of phytotoxic
compounds (Table 1). Among the most well-characterized bac-
terial phytotoxins are those produced by the plant pathogen
Pseudomonas syringae. This review summarizes our current
understanding of the mechanism of action, biosynthesis, and
regulation of four distinct classes of phytotoxins, including the
lipodepsipeptides (syringomycins, syringopeptins), corona-
tines, phaseolotoxin, and tabtoxin.
Biology and Pathogenicity of P. syringae
P. syringae is reported to induce a wide variety of symptoms
on plants, including blights (rapid death of tissue), leaf spots,
and galls. The species is divided into pathogenic variants
(pathovars), which vary in host range. Two distinct reactions
are possible when P. syringae cells are infiltrated into plant
tissue. One potential outcome is a compatible, susceptible in-
teraction which is characterized by a symptom called water
soaking, a reaction which is followed by pathogen proliferation
and advanced symptom development. In contrast, resistant
host cells undergo a reaction known as the hypersensitive re-
sponse and become necrotic 12 to 24 h after inoculation. A
cluster of genes termed the hrp region (for “hypersensitive
response and pathogenicity”) is conserved in phytopathogenic
prokaryotes and affects the ability of a bacterium to induce a
hypersensitive response in nonhost plants, pathogenicity in
host plants, and the ability to grow within or on the surface of
plants (83). It is important to note that the hrp gene cluster is
required for pathogenicity of P. syringae on plant hosts. The hrp
genes are known to encode genes for the regulation and bio-
synthesis of a type III secretion pathway that is similar in both
plant and animal pathogens and is used to secrete virulence
proteins (228). It is becoming increasingly evident that mech-
anisms which function in clinical pathogens of animals, such as
the type III secretion systems in Salmonella, Shigella, and Yer-
sinia, are similar to those in phytopathogenic species (206,
221). However, in addition to the hrp genes, phytopathogenic
pseudomonads encode gene products that significantly en-
hance pathogen virulence, including extracellular polysaccha-
rides, phytotoxins, cell wall-degrading enzymes, and phytohor-
mones (3, 49, 56, 92).
Phytotoxins Produced by P. syringae
Phytotoxins are products of plant pathogens or of the host-
pathogen interaction that directly injure plant cells and influ-
ence the course of disease development or symptoms. Both
fungal and bacterial pathogens produce a number of secondary
metabolites that are toxic to plant cells; however, these metab-
olites may not be important in plant disease. Consequently,
phytopathologists have developed criteria for assessing the in-
volvement of toxins in plant disease. These include (i) repro-
duction of disease symptoms with the purified toxin, (ii) a
correlation between toxin yield and pathogenicity, (iii) produc-
tion of the toxin during active growth of the pathogen in
planta, and (iv) reduced virulence or lack of virulence in non-
toxigenic strains. Phytotoxins may be host specific and exhibit
the same specificity as the producing pathogen, or they may
lack specificity and exhibit a wider host range of activity than
the producing pathogen. Most toxins produced by P. syringae
lack host specificity and cause symptoms on many plants which
cannot be infected by the toxin-producing pathogen.
Visual assessment of phytotoxin production in planta can be
somewhat subjective. The phytotoxins produced by P. syringae
generally induce chlorosis (coronatine, phaseolotoxin, and tab-
toxin) or necrosis (syringomycin and syringopeptin). However,
studies of particular phytotoxins are probably influenced by the
visible evidence of their activity. Some phytotoxins may instead
act by changing metabolic processes in the host in such a way
that the deleterious activity might be manifested only at the
biochemical level.
Although phytotoxins are not required for pathogenicity in
P. syringae, they generally function as virulence factors for this
pathogen, and their production results in increased disease
severity. For example, P. syringae phytotoxins can contribute to
systemic movement of bacteria in planta (198), lesion size (24,
287), and multiplication of the pathogen in the host (24, 75,
172). The phytotoxins produced by P. syringae can substantially
enhance the virulence of producing pathogens, even though
some disease can occur in their absence.
TABLE 1. Phytotoxins produced by Pseudomonas spp.
Toxin Producing organism Chemical class or biosynthetic origin Reference(s)
Coronatine P. syringae pv. atropurpurea, glycinea,
maculicola, morsprunorum, tomato
Polyketide 108
Corpeptin P. corrugata Lipodepsipeptide 68
Fuscopeptin P. fuscovaginae Lipodepsipeptide 10
Persicomycins P. syringae pv. persicae Fatty acid 17
Phaseolotoxin P. syringae pv. actinidiae, phaseolicola Sulfodiaminophosphinyl peptide 157
Rhizobitoxine P. andropogonis Vinylglycine 167
Syringomycinsa P. syringae pv. syringae, aptata, atrofaciens Lipodepsinonapeptide 12, 13, 77, 275
P. fuscovaginae 19
Syringopeptins P. syringae pv. syringae Lipodepsipeptide 9
Tabtoxin P. syringae pv. tabaci, coronafaciens, garcae b-Lactam 255
Tagetitoxin P. syringae pv. tagetis Unknown 217
Tolaasin P. tolaasii Lipodepsipeptide 211
Viscosin P. marginalis (P. fluorescens) Lipodepsipeptide 134
a Includes the related toxins syringotoxin, syringostatin, and pseudomycin.
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BIOSYNTHESIS OF PHYTOTOXINS BY
NONRIBOSOMAL ENZYME SYSTEMS
The toxins produced by P. syringae are varied in origin and
include monocyclic b-lactam (tabtoxin), sulfodiaminophosphi-
nyl peptide (phaseolotoxin), lipodepsinonapeptide (syringomy-
cin), and polyketide (coronatine) structures (163). Knowledge
of phytotoxin structure is extremely important since structural
information may provide important clues about the biosyn-
thetic processes involved. Fortunately, several P. syringae phy-
totoxins have structural analogies to antibiotics that are pro-
duced via nonribosomal mechanisms in Streptomyces and
Bacillus spp. These pathways have served as predictive models
for the synthesis of selected phytotoxins.
It has been difficult to obtain information on intermediates
in the biosynthetic pathways to various phytotoxins. One rea-
son for the lack of characterized intermediates in these diverse
pathways is that nonribosomal synthesis is generally catalyzed
by multifunctional proteins or polypeptide complexes and in-
termediates are transferred between enzymatic domains and
not released into the cytoplasm. Furthermore, conversion of
intermediates to the final product may occur very rapidly and
impede detection and characterization.
Peptide Synthetases
The biosynthesis of nonribosomal peptides has been inten-
sively investigated for a number of years, and there are several
excellent reviews on this subject (126, 147, 247, 278). Accord-
ing to the current model, these peptides are synthesized via a
thiotemplate mechanism by large multisubunit enzymes rang-
ing from 100 to 1,600 kDa (247). All thiotemplate multienzy-
matic systems are composed of amino acid-activating domains
that catalyze the adenylation of the constituent amino acids
and the formation of thioesters. The general sequence of re-
actions includes (i) carboxyl activation of the substrate amino
acid by adenylate formation, (ii) acylation of enzyme-attached
pantothenoyl-thiols, and (iii) directed transfer to the next acyl
intermediate with condensation (Fig. 1A). The completed pep-
tide is released from the enzyme complex by cyclization, ami-
dation, or hydrolysis (126).
The isolation, sequencing, and characterization of genes en-
coding multifunctional peptide synthetases has indicated a
multidomain arrangement in which an adenylation domain
consisting of 600 amino acid residues is highly conserved and
repeated. Biochemical studies with specific domains have con-
firmed the multidomain structure predicted by sequence data
(147). An elongation domain of about 500 amino acids sepa-
rates successive adenylation domains (54). The organization of
the multifunctional peptide synthetase is colinear to the amino
acid sequence of the corresponding peptide product (247).
Turgay et al. (266) described a superfamily of adenylate-form-
ing enzymes which includes all peptide synthetases and several
adenylating enzymes. A typical adenylation-thiolation module
of a peptide synthetase contains a series of conserved se-
quences with the same order and spacing (252). Five regions
originally designated as core motifs (266) are conserved in the
adenylation domain of peptide synthetases (Fig. 1B). Although
the function of core 1 remains unknown, cores 2 to 5 are
presumed to be involved in ATP binding and hydrolysis (Fig.
1B). Core 2 has a glycine-rich sequence that contains a poten-
tial phosphate-binding loop, whereas core 4 shows relatedness
to ATPases. Conti et al. (47) identified a substrate-binding
pocket between cores 2 and 3 of a gramicidin S synthetase
module by analysis of the crystal structure of the adenylation
FIG. 1. (A) Reaction sequence catalyzed by multifunctional peptide synthetases. (a) Carboxyl activation of the first amino acid (A1) and formation of the aminoacyl
adenylate; (b) activation of the second amino acid (A2) and formation of the aminoacyl adenylate; and (c) the condensation reaction. Abbreviations: Enz, enzyme; A,
amino acid, M, divalent metal ion (Mg21, Mn21, Ca21). Numbering indicates specific domains within an individual multienzyme; for example, Enz1 and Enz2 are two
distinct domains within the same enzyme. Amino acids (A1 and A2) are two individual amino acids. For additional information, see reference 278. (B) Domain structure
of the amino acid-activating module SyrE1. The SyrE1 module contains approximately 1,500 amino acids organized into four domains as defined by Stein and Vater
(252). The relative positions of conserved core sequences are shown for each domain. The two elongation domains contain a characteristic HHxxxDG motif (E) (54).
The five core sequences described by Stachelhaus and Marahiel (247) are located within the amino acid-adenylating domain. Core 2 has a sequence (SGTTGxPKGV)
resembling the Walker type A motif involved in ATP binding, and the core 4 sequence (TGD) carries a motif associated with ATPase activity. A role in catalyzing
aminoacyl adenylate formation is suggested for cores 3 and 5 (247). A region between cores 2 and 3 is associated with substrate recognition (S) (47), and SyrE1 exhibits
substrate specificity for L-Ser (95). Core 6, with a characteristic LGGHSL motif, is located in the 49-phosphopantetheine carrier domain. The motif contains a conserved
serine to which the 49-phosphopantetheine cofactor is covalently attached, which in turn is the site of thioester formation. The next module, SyrE2, carrying three
domains (i.e., amino acid adenylating, 49-phosphopantetheine carrier, and elongation domains), follows the SyrE1 module.
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domain. Substrate specificity in various peptide synthetases is
presumably mediated by the amino acids lining the substrate-
binding pocket. Core 6, which is located in the 4-phospho-
pantetheine carrier domain adjacent to the adenylation
module (Fig. 1B), is associated with covalent binding of the
substrate amino acid and contains a serine residue to which
the cofactor 49-phosphopantetheine is covalently attached
(147).
The involvement of peptide synthetases and adenylate-form-
ing enzymes in the biosynthesis of coronatine and syringomycin
has been established and is discussed in further detail below.
Polyketide Synthases
Polyketides constitute a huge family of structurally diverse
natural products including those with antibiotic, chemothera-
peutic, and antiparasitic activities. Most of the research on
polyketide synthesis in bacteria has focused on compounds
synthesized by Streptomyces or other actinomycetes, and sev-
eral excellent reviews have been recently published (99, 116,
123). However, in addition to coronatine, it is important to
note that Pseudomonas produces a variety of antimicrobial
compounds from the polyketide pathway, including mupirocin
(pseudomonic acid) (73), pyoluteorin (52), and 2,4-diacetyl-
phloroglucinol (14).
Polyketide synthesis is related to fatty acid biosynthesis; the
latter begins with the condensation of acetyl coenzyme A
(acetyl-CoA) (starter unit) and malonyl-CoA (chain extender
unit) and then proceeds with a cycle of modifications on the
carbonyl group of malonyl-CoA (i.e., reduction to a hydroxyl,
dehydration to produce a double bond, and further reduction
to form a saturated fatty acid) (Fig. 2). Unlike fatty acid syn-
thases, a polyketide synthase (PKS) can accept additional sub-
strates in the starter and extender groups and the products vary
in the extent of reduction. PKSs are generally classified as type
I or II systems and consist of protein complexes that act on
covalently bound substrates that are attached as thioesters to
an acyl carrier protein (ACP) (117). Polyketides synthesized by
type I PKSs usually have a fairly reduced structure and are
synthesized by large multifunctional proteins that consist of
individual domains which catalyze specific and discrete reac-
tions in a nonreiterative fashion (Fig. 3) (102). The functional
activities catalyzed by domains within the type I PKS are often
apparent in the structure of the growing polyketide chain (Fig.
3C), and nucleotide sequencing has become an important tool
in predicting the biosynthetic route to polyketides synthesized
by a type I PKS. Conversely, type II PKSs are most often
associated with synthesis of aromatic polyketides, and biosyn-
thesis occurs on monofunctional proteins that associate in a
complex. Unlike the type I system, the type II PKS may utilize
one or more enzymes in a reiterative fashion.
CORONATINE
The structure of coronatine (COR) (Fig. 4a) is unusual and
has two distinct components: the polyketide coronafacic acid
(CFA) (Fig. 4f) and coronamic acid (CMA), an ethylcyclopro-
pyl amino acid derived from isoleucine (108, 160, 196). COR is
generally the predominant coronafacoyl compound synthe-
sized by COR producers and also the most toxic; however,
other coronafacoyl compounds which contain various amino
acid substituents conjugated to CFA via an amide linkage may
be synthesized (Fig. 4b to e) (161, 165, 166, 169).
Generalized Biosynthetic Route
Precursor feeding studies with 13C-labeled substrates dem-
onstrated that CFA is a novel polyketide synthesized from one
unit of pyruvate, one unit of butyrate, and three acetate resi-
dues (196) (Fig. 5). Recent studies have suggested that the
pyruvate used for CFA biosynthesis is converted into a-keto-
glutarate before incorporation to CFA and that a-ketogluta-
rate may serve as the starter unit for CFA assembly (194).
Little information is available about potential intermediates in
the biosynthetic route to CFA, probably because such inter-
mediates remain enzyme bound. However, Mitchell et al. (171)
have identified a cyclopentenone compound, 2-(1-oxo-2-cyclo-
penten-2-ylmethyl)butanoic acid, which may function as an
intermediate or shunt product of the CFA biosynthetic path-
way.
Parry et al. (195) provided an important clue about the route
to CMA by demonstrating that L-alloisoleucine was a more
immediate precursor to CMA than was isoleucine. Initially,
two possible pathways to COR from CFA were proposed;
one route involved the direct coupling of isoleucine (or alloi-
soleucine) to CFA to form the coronafacoyl conjugates coro-
nafacoylisoleucine (CFA-Ile), and coronafacoylalloisoleucine
FIG. 2. Reaction sequence in the synthesis of fatty acids. The starting units
for the fatty acid synthase are acetyl-CoA and malonyl-CoA; these are converted
into acetyl-ACP and malonyl-ACP by acetyl and malonyl transacylase, respec-
tively. The fatty acid synthase proceeds with the condensation of these two
precursors and then continues with a cycle of reduction, dehydration, and further
reduction of the keto group (asterisk). Two key differences between polyketide
synthases (PKS) and fatty acid synthase include the choice of starter units and
the extent of reduction.
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(CFA-aIle), followed by an oxidative cyclization on the amino
acid moiety of the conjugate to form COR (289). This scheme
was proposed based on the natural occurrence of CFA-Ile and
CFA-aIle in a variety of COR producers (169). An alternative
route involved the isomerization of isoleucine to form alloiso-
leucine, cyclization of alloisoleucine to form CMA, and con-
jugation of CFA and CMA via amide bond formation (Fig. 5).
Support for the latter route developed from the demonstration
of CMA as a defined intermediate in the COR pathway (170).
The biosynthetic block to COR in several mutants was elimi-
nated when CMA was exogenously supplied, and other mu-
tants were found to excrete CMA when CFA synthesis was
blocked (22, 170). Furthermore, CFA-negative mutants could
produce COR when supplied with exogenous CFA but not
with CFA-Ile or CFA-aIle, indicating that the latter com-
pounds were not operative in coronatine synthesis (170). Our
FIG. 3. Biosynthesis of erythromycin A. (A) The nucleotide sequence of the eryA region contains three ORFs designated eryAI, eryAII, and eryAIII (29, 60). (B)
These genes encode three proteins which constitute erythromycin B synthetase (DEBS); these are designated DEBS 1, DEBS 2, and DEBS 3 (39). (C) Each DEBS
protein contains two modules, each with domains for acetyltransferase (AT), ACP, and b-keto synthase (KS) activity. Some modules contain additional domains for
dehydratase (DH), enoyl reductase (ER), ketoreductase (KR), and TE activity. (D) Cyclization and release of the DEBS 3 product results in the formation of
6-deoxyerythronolide B (DEB), and additional tailoring steps result in the production of erythromycin A (E). Modified from reference 99.
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current understanding of the COR biosynthetic pathway is
summarized in Fig. 5.
The final step in the pathway to COR is presumed to be the
ligation or coupling of CFA and CMA by an amide linkage.
The enzyme(s) catalyzing this reaction is thought to lack rigid
specificity for the amino acid substrate since a variety of coro-
nafacoyl-amino acid conjugates have been isolated, including
CFA-Ile, CFA-aIle, coronafacoylvaline, norcoronatine, and
CFA conjugated to serine and threonine (161, 165, 166, 169).
Biological Effects and Mode of Action
The primary symptom elicited by COR is a diffuse chlorosis
that can be induced on a wide variety of plant species (82).
Interestingly, the reaction of Arabidopsis thaliana to exog-
enously applied COR is atypical; instead of chlorosis, antho-
cyanins accumulate at the site of inoculation and the tissue
develops a strong purple hue (27). COR is also known to
induce hypertrophy, inhibit root elongation, and stimulate eth-
ylene production (74, 122, 226, 277). Several research groups
have noted the remarkable structural and functional homolo-
gies between COR and methyl jasmonate (MeJA), a plant
growth regulator derived from the octadecanoid signaling
pathway which is elicited by biological stress (241, 280). COR
and MeJA induce analogous biological responses in Arabidop-
sis seedlings, Eschscholtzia californica cell cultures, and potato
tissue; these results have led researchers to suggest that COR
functions as a molecular mimic of the octadecanoid signaling
molecules produced by higher plants (75, 85, 129, 276, 283).
Furthermore, Feys et al. (75) generated a coronatine-insensi-
tive (coi1) mutant of Arabidopsis that was insensitive to the effects
of both COR and MeJA, suggesting a similar mode of action.
Light microscopy was used to compare the effects of COR,
CFA, and MeJA on tomato tissue (190). Several changes were
induced in tomato tissue exposed to the phytotoxin; for exam-
ple, the epidermal wall was significantly thicker in COR-
treated tissue and the chloroplasts stained more intensively
and were smaller (190). One of the most pronounced differ-
ences was the appearance of spherical and cubical protein-
aceous structures in the vacuole of COR-treated tomato tissue.
These structures were markedly similar to the proteinase in-
hibitors which had been previously found in plant tissues ex-
FIG. 4. Structures of COR and coronafacoyl compounds.
FIG. 5. Biochemical pathways involved in the synthesis of COR and coronafacoyl compounds in P. syringae pv. glycinea PG4180. COR consists of a polyketide
component, CFA, coupled (CPL) via amide-bond formation to an amino acid component, CMA. CFA is synthesized as a branched polyketide from three acetate units,
one pyruvate unit, and one butyrate unit via an unknown sequence of events (196). CMA is derived from isoleucine via alloisoleucine and cyclized by an unknown
mechanism (160, 195). CMA functions as an intermediate in the COR biosynthetic pathway, which indicates that cyclization of L-alloisoleucine to form CMA occurs
before CFA and CMA are coupled (170). The coronafacoyl analogues, CFA-Ile and CFA-aIle result from amide bond formation between CFA and isoleucine and
alloisoleucine, respectively, and are not utilized further in the synthesis of COR.
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posed to various biological stresses (2, 243, 244). The presence
of proteinase inhibitors in the COR-treated tissue was con-
firmed by demonstrating that this tissue significantly inhibited
the activity of both chymopapain and chymotrypsin (190). Re-
cently, polyclonal antibodies to both chymopapain (34) and
chymotrypsin (225) inhibitors were used to confirm the identity
of the proteinaceous structures in COR-treated tomato tissue.
When COR-treated tissue was incubated with antisera to chy-
mopapain inhibitor and then with a secondary antibody con-
jugated to gold, the cubical crystals were densely labeled with
gold particles, indicating that these structures were chymopa-
pain inhibitor (188). A similar experiment indicated that the
spherical crystals were chymotrypsin inhibitor (188); thus, we
concluded that both chymopapain and chymotrypsin inhibitors
are specifically induced in response to COR in tomato tissue.
Although COR, CFA, and MeJA induced the production of
proteinase inhibitors, only COR caused cell wall thickening,
changes in chloroplast structure, and chlorosis; CFA and
MeJA did not induce these changes in tomato tissue (190).
Consequently, the CMA moiety, or perhaps the amide linkage
between CFA and CMA, may impart additional biological
activities to COR in tomato. Further differentiation of COR
and MeJA was demonstrated by Krumm et al. (131), who
showed that jasmonic acid and COR induce the production of
distinctly different volatile compounds in Phaseolus lunatus.
Therefore, COR does not function solely as a molecular mimic
of MeJA in some plant species, and the mechanism of action of
COR may remain unclear until putative receptors for the toxin
are localized in various plant species.
Genetic Studies and Involvement of Plasmids in Production
Production of the phytotoxin COR has been demonstrated
in five pathovars of P. syringae, i.e., pv. atropurpurea, glycinea,
maculicola, morsprunorum, and tomato, which infect ryegrass,
soybean, crucifers, Prunus spp., and tomato, respectively (159,
168, 282). Although production of COR outside the species P.
syringae is thought to be rare, Xanthomonas campestris pv.
phormiicola, a pathogen of New Zealand flax, also produces
several coronafacoyl compounds (162, 261).
Tn5 mutagenesis has been used to obtain COR-defective
(COR2) mutants of P. syringae pv. atropurpurea, glycinea,
morsprunorum, and tomato (23, 25, 176, 289). In several stud-
ies, COR was shown to play a distinct role in virulence (24, 172,
229); however, it is important to note that strains of P. syringae
pv. glycinea, maculicola, morsprunorum, and tomato that do
not produce COR have been isolated (159, 168, 271). Several
reports have shown that the COR biosynthetic cluster occurs
on indigenous plasmids (23, 25, 138, 229, 297); consequently,
the potential instability of plasmid-located COR genes might
explain the variability in COR production among strains of P.
syringae (51, 271). Although the COR gene cluster has been
frequently associated with large (80- to 110-kb) plasmids, these
genes can also be chromosomal (51).
Biosynthesis in P. syringae pv. glycinea PG4180
COR biosynthesis has been intensively studied in P. syringae
pv. glycinea PG4180 because this strain is easy to manipulate
genetically, consistently synthesizes large amounts of COR in
vitro (20 to 40 mg/liter), and infects soybean, a host which is
easy to cultivate (26). Transposon mutagenesis indicated that
the COR biosynthesis genes in P. syringae pv. glycinea PG4180
are located on a 90-kb plasmid designated p4180A (25). The
involvement of p4180A in COR production was demonstrated
by transforming this plasmid into two nonproducers of COR,
P. syringae pv. syringae PS51 and PS61 (22). Organic acids were
then extracted from PS51 and PS61 transformants containing
p4180A and analyzed by high-pressure liquid chromatography
(HPLC) and combined gas chromatography-mass spectrome-
try. PS51 and PS61 transformants containing p4180A produced
both CFA and COR, indicating that p4180A encodes all genes
necessary for the biosynthesis of coronafacoyl compounds in P.
syringae (22).
A variety of approaches have been used to characterize the
COR biosynthetic cluster encoded by p4180A: (i) saturation
Tn5 mutagenesis, (ii) feeding studies using exogenously sup-
plied CFA and CMA, (iii) complementation of selected mu-
tants with cloned DNA, (iv) expression of selected regions of
the COR gene cluster in COR nonproducers, and (v) nucleo-
tide sequence analysis (22, 143, 203, 213, 270, 272, 273, 289).
Saturation Tn5 mutagenesis indicated that a 32-kb contiguous
region was absolutely required for COR biosynthesis, and a
physical map was developed by using the restriction enzymes
BamHI and SstI (Fig. 6C) (22, 272, 289). Two regions in the
COR biosynthetic cluster contained structural genes for CMA
and CFA biosynthesis; these were separated by a 3.4-kb regu-
latory region (REG; Fig. 6B). Transcripts in the COR biosyn-
thetic gene cluster were identified by a combination of the
following approaches: (i) complementation of selected mu-
tants with subcloned DNA from the COR biosynthetic cluster,
(ii) expression of functional regions of the COR gene cluster in
COR nonproducers, (iii) nucleotide sequence and primer ex-
tension analyses, and (iv) transcriptional fusions to a promot-
erless glucuronidase gene (142, 213, 270, 272, 273). These
approaches indicated that the COR gene cluster in PG4180
consists of six transcripts (Fig. 6A).
The nucleotide sequence of the 6.9-kb region containing the
CMA biosynthetic gene cluster revealed the presence of four
genes designated cmaA, cmaB, cmaT, and cmaU (37, 197, 270)
(Fig. 6A). The CMA biosynthetic gene cluster was shown to
encode two transcripts; one transcript was monocistronic and
contained cmaU, and the second was polycistronic and con-
tained three cotranscribed genes designated cmaA, cmaB, and
cmaT (Fig. 6A). Start sites for both transcripts were deter-
mined by primer extension (270). The deduced amino acid
sequence of cmaA indicated that the enzyme contains an
amino acid-activating domain, whereas cmaB showed extensive
homology to syrB2, a gene encoding an enzyme required for
syringomycin synthesis (94, 95, 292). The deduced amino acid
sequence of cmaT suggested that it functions as a thioesterase
(TE), providing further support to the role of a thiotemplate
mechanism for CMA biosynthesis (270). CmaT has now been
overproduced in E. coli, and assays with a variety of esters and
thiolesters indicated that the overproduced protein was a func-
tional esterase in vitro (197). However, sequence analysis of
cmaU has failed to reveal anything useful about its potential
function in CMA biosynthesis.
A region required for the coupling of CFA and CMA via
amide bond formation was sequenced, and a 1.4-kb gene des-
ignated cfl (coronafacate ligase) was identified (Fig. 6D) (22,
143). Cfl is most closely related to enzymes that activate car-
boxylic acids by adenylation; consequently, this enzyme may
catalyze the adenylation of CFA and the ligation of the CFA-
adenylate to CMA. Coronafacate ligase has been overpro-
duced in Escherichia coli and P. syringae in soluble form (214).
Although the precise function of the enzyme remains unclear,
construction of a nonpolar mutation in cfl suggested that the
enzyme may also function in CFA biosynthesis (214).
Complementation experiments with CFA-defective mutants
and an extensive series of subclones demonstrated that the
cfl-CFA region was contained in a single 19-kb transcriptional
unit (Fig. 6A) (142). Transcriptional fusions to a promoterless
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glucuronidase gene and primer extension analysis indicated
that transcription initiated upstream of cfl in SstI fragment 8
and proceeded through SstI fragment 4 (142, 143) (Fig. 6). The
59 end of the transcript contains six discrete ORFs including cfl
and cfa1 to cfa5 (143, 203) (Fig. 6D). Sequence analysis of cfa1,
cfa2, and cfa3 revealed relatedness to ACP, fatty acid dehy-
dratase, and b-ketoacyl synthetase, respectively (203). The
function of cfa4 could not be predicted from database
searches, whereas the translation product of cfa5 showed re-
latedness to acyl-CoA ligases (203). Both cfa1 and cfa3 were
overexpressed in E. coli, and protein products close to the
predicted size were visualized by sodium dodecyl sulfate-poly-
acrylamide gel electrophoresis (203).
The continued sequencing of SstI fragments 5 and 6 indi-
cated the presence of two large open reading frames (ORFs)
that were designated cfa6 (8.0 kb) and cfa7 (6.2 kb) (Fig. 6D)
(212). Both proteins exhibit a high degree of similarity to
6-deoxyerythronolide B synthase (Fig. 3), suggesting that a
type I PKS participates in CFA synthesis. Both Cfa6 and Cfa7
were overproduced in E. coli and shown to encode multifunc-
tional PKSs with antigenic similarity to DEBS 2 (212). Two
additional genes, cfa8 and cfa9, mapped downstream of cfa7
(Fig. 6D); cfa8 was required for the biosynthesis of both CFA
and COR, and the predicted translational product showed
similarity to crotonyl-CoA reductases from Streptomyces spp.
(213). Crotonyl-CoA reductase catalyzes one step in the con-
version of acetoacetyl-CoA to butyryl-CoA, and the latter
product is used as a 4C extender in polyketide synthesis (80).
Consequently, the recruitment of a ccr gene into the CFA gene
cluster may reflect the requirement of butyryl-CoA as a pre-
cursor for CFA synthesis. cfa9 showed relatedness to thioes-
terases (TEs) involved in the synthesis of gramicidin, tyroci-
dine, and tylosin (130, 155, 178). Furthermore, Cfa9 contained
the GxSxG and GxH motifs characteristic of diisopropyl flu-
orophosphate-sensitive animal and avian TEs (43). Analysis of
a cfa9 mutant indicated that this gene was dispensable for CFA
and COR production but may increase the release of enzyme-
bound products from the COR pathway (213). The complete
nucleotide sequence of the CFA biosynthetic gene cluster has
facilitated the development of a model which incorporates the
activities of both the mono- and multifunctional proteins (212).
Regulation of Production
A variety of nutritional and environmental factors have been
examined for their effect on COR production in P. syringae pv.
glycinea PG4180 (189). Temperature had a highly significant
effect on COR biosynthesis in P. syringae pv. glycinea PG4180,
with maximal production at 18°C and negligible yields at 30°C
(189). Interestingly, growth of PG4180 was relatively unaf-
fected over a range of temperatures tested (14 to 30°C). This
response to temperature is consistent with symptom develop-
ment in the field, since P. syringae pv. glycinea is predominantly
a cool-weather pathogen. CFA and CMA were also subject to
the same pattern of temperature control, with optimal produc-
tion at 18°C (187, 270). Recently, Rohde et al. (220) showed
that COR production was thermoregulated in selected strains
of P. syringae pv. atropurpurea, maculicola, morsprunorum,
and tomato, which may indicate that temperature is a common
regulatory control for COR biosynthesis in other pathovars of
P. syringae.
The production of both CFA and CMA in PG4180 is regu-
lated at the transcriptional level by temperature. Transcrip-
tional fusions of the CFA and CMA promoter regions to a
promoterless glucuronidase gene indicated that transcriptional
activity in both biosynthetic gene clusters was maximal at 18°C
and significantly lower at 28°C (142, 191, 214, 270). The higher
level of transcriptional activity for the CMA and CFA biosyn-
thetic promoters at 18°C helps explain why COR production is
optimal at this temperature.
A regulatory region was isolated which controls both CFA
and CMA production; the nucleotide sequence of this region
revealed the presence of three genes, corP, corS, and corR (Fig.
6A) (273). The deduced amino acid sequences of corP and
corR indicated relatedness to response regulators that function
as members of two-component regulatory systems, and the
translational product of corS showed sequence similarity to
histidine protein kinases which function as environmental sen-
sors (273). Response regulators control the adaptive response
in two-component regulatory systems and are characterized by
an N-terminal receiver domain which functions as the phos-
phorylation site and a C-terminal effector domain with a DNA-
binding, helix-turn-helix (H-T-H) motif (192, 193). Both
FIG. 6. Functional and physical map of the COR biosynthetic gene cluster. (A) Horizontal lines with arrowheads indicate the transcriptional organization of the
COR gene cluster. (B) Functional regions of the COR biosynthetic cluster: CMA, CMA biosynthetic gene cluster; REG, regulatory region; CFA, CFA biosynthetic
gene cluster. (C) Physical map of the COR gene cluster; the enzymes used for restriction mapping were BamHI and SstI. (D) Expanded view of SstI fragments 4 to
8, which contain the CFA biosynthetic gene cluster. Abbreviations: 1, cfa1; 2, cfa2; 3, cfa3; 4, cfa4; 9, cfa9.
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domains are strongly conserved in CorR; CorP, however, con-
tains the highly conserved receiver domain (at least two aspar-
tate residues and a conserved lysine) but lacks the H-T-H
motif. The N-terminal receiver domains of CorR and CorP are
almost identical when aligned, suggesting a shared specificity
for the same phosphodonor protein(s). The COR regulatory
system is modified from the two-component paradigm since it
contains two response regulator proteins together with a single
sensor protein.
Both CorR and CorP showed relatedness to response regu-
lators in the ROIII group, which includes NarL, BvgA, and FixJ
(193). Several of these response regulators function as positive
activators of transcription and bind to specific target sequences
upstream of the promoters they regulate (1, 36). Complemen-
tation analysis of a corR mutant, PG4180.P2, and transcrip-
tional fusions to a promoterless glucuronidase gene (uidA)
indicated that CorR functions as a positive regulator of COR
gene expression (202). Deletion analysis of the cfl upstream
region was used to define the minimal amount of DNA re-
quired for full transcriptional activity of a cfl::uidA fusion
(202). A fragment located upstream from the cfl transcrip-
tional start site was used in gel retardation and DNase I foot-
printing assays to define the specific bases bound by CorR.
This region was also conserved in the promoter region for
cmaA, suggesting that both the CFA and CMA structural
genes are controlled by CorR, a positive activator of COR
gene expression (202).
Gene fusions indicated that expression of corR and corP was
not significantly different at 18 and 28°C. In contrast, expres-
sion of corS was regulated by temperature, and a corS::uidA
fusion showed maximal transcriptional activity at 18°C and
15-fold less activity at 28°C (273). The use of transcriptional
fusions and complementation analyses indicated that each reg-
ulatory gene was independently transcribed (Fig. 6A). Further-
more, experiments with the corS::uidA fusion indicated that
transcription of corS was autoregulated and required func-
tional copies of corR, corS, and corP (273).
COR production in PG4180 was significantly affected by the
carbon source, glucose levels, amino acid supplements, com-
plex carbon and nitrogen sources, and osmolarity (189). Tran-
scriptional fusions were used to determine if any of these
factors impacted transcriptional activity in the COR gene clus-
ter (191). Glucose levels and selected carbon and amino acid
sources significantly affected the expression of the cfl and
cmaA operons. In general, gene expression increased with in-
creasing amounts of glucose but was strongly repressed when
selected carbon sources (xylose and fructose) and amino acids
(isoleucine and valine) were added to the medium. Interest-
ingly, changes in osmolarity and the addition of complex C and
N sources did not significantly affect COR gene expression. In
contrast, several researchers have shown that transcription of
the hrp and avirulence genes (avr) genes in P. syringae is re-
pressed by complex C and N sources and by increased osmo-
larity (106, 109, 144, 210, 227). Furthermore, the hrp and avr
genes were shown to be transcriptionally activated in response
to fructose (106, 144, 227). Obviously, some of the signals for
activation of the hrp and COR gene clusters are different.
Several approaches have been used to investigate the poten-
tial stimulation of COR synthesis by host plants. Palmer and
Bender amended the growth medium for PG4180 with extracts
from soybean tissue or with plant-derived secondary metabo-
lites but found no evidence that these substances substantially
increased COR production in vitro (189). In a subsequent
study, the activities of cmaA::uidA and cfl::uidA transcriptional
fusions were compared in vitro and in soybean leaves; however,
there was no evidence that COR gene expression in PG4180
was higher in plant tissue (188). In contrast, Ma et al. (145)
showed that COR biosynthesis in P. syringae pv. tomato
DC3000 is plant inducible. Gene fusions indicated that a single
transcriptional unit designated CorII was expressed at a higher
level in planta than in vitro. Other results indicate that shikimic
and quinic acids may be signals for COR gene induction in
DC3000 (137). These observations suggest that the signals for
induction of COR synthesis differ in PG4180 and DC3000.
SYRINGOMYCIN AND RELATED
LIPODEPSINONAPEPTIDES
Syringomycin is representative of the cyclic lipodepsinon-
apeptide class of phytotoxins, which are composed of a polar
peptide head and a hydrophobic 3-hydroxy fatty acid tail (77,
240) (Fig. 7). Characteristically, three forms of syringomycin
are produced, differing only by the length of the 3-hydroxy fatty
acid moiety, which is either decanoic (SRA1), dodecanoic
(SRE), or tetradecanoic (SRG) acid. An amide bond attaches
the 3-hydroxy fatty acid to an N-terminal serine residue, which
in turn is linked to 4-chlorothreonine at the C terminus by an
ester linkage to form a macrocyclic lactone ring. Other distinc-
FIG. 7. Structures of syringomycin, syringostatin, syringotoxin, and pseudomycin. The four lipodepsinonapeptides differ in the amino acid sequence between
positions 2 and 6. The 3-hydroxy fatty acyl group is a derivative of either decanoic acid (syringomycin), dodecanoic acid (syringomycin and syringostatin), tetradecanoic
acid (all four lipodepsinonapeptides), or hexadecanoic acid (pseudomycin); some forms of pseudomycin are acylated by 3,4-dihydroxytetradecanoate or 3,4-dihydroxy-
hexadecanoate. Abbreviations of nonstandard amino acids: Asp(3-OH), 3-hydroxyaspartic acid; Dab, 2,4-diaminobutyric acid; Dhb, 2,3-dehydroaminobutyric acid; Hse,
homoserine; Orn, ornithine; Thr(4-Chl), 4-chlorothreonine; aThr, allothreonine.
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tive structural features are a trio of uncommon amino acids
(2,3-dehydroaminobutyric acid, 3-hydroxyaspartic acid, and
4-chlorothreonine) at the C terminus and the presence of D-
isomers of serine and 2,4-diaminobutyric acid (231). Chlorina-
tion of the syringomycin molecule is important for biological
activity (86). Syringomycin is produced by most strains of P.
syringae pv. syringae isolated from a wide range of host plants.
Syringotoxin and syringostatin are related lipodepsinonapep-
tides produced by strains isolated from citrus and lilac hosts,
respectively (13, 76). The saprophytic strain MSU 16H from
barley produces a fourth type of lipodepsinonapeptide called
pseudomycin (12). All the lipodepsinonapeptides differ in
amino acid sequence between positions 2 and 6, as depicted in
Fig. 7. Despite these structural differences, the various types of
lipodepsinonapeptides exhibit similar degrees of biological ac-
tivity (245).
Syringomycin Activity Is Centered Around
Transmembrane Pore Formation
Syringomycin induces necrosis in plant tissues, and early
studies of its mode of action established that the plasma mem-
brane of host cells is the primary target (8, 199). The amphi-
pathic lipopeptide structure of syringomycin promotes its in-
sertion into the lipid bilayers of membranes to form pores that
are freely permeable to cations (105). The toxin causes an
increase in transmembrane fluxes of K1, H1, and Ca21 that
are deadly to cells (32, 182, 258). Pore formation in lipid
bilayers is a highly efficient process based on evidence that only
nanomolar amounts of syringomycin are required for measur-
able activity. This is especially apparent in assays of tobacco
protoplasts, where 45Ca21 influx and membrane lysis occur at
a threshold syringomycin concentration of 50 ng/ml (103). Fur-
thermore, Hutchison et al. (105) demonstrated pore-forming
activity for SRE in a pure black-lipid membrane, thereby show-
ing that the activity does not arise from opening of native ion
channels found in membranes patched from cells. Many med-
ically important bacteria produce pore-forming proteins or
peptides that cause cytolysis as a result of massive ion fluxes
(31). Syringomycin represents the first example of a virulence
factor from a plant-pathogenic bacterium that targets host
plasma membranes to form ion channels in lipid bilayers and
causes cytolysis (103, 105).
From biophysical analysis of channel formation in planar
lipid bilayer membranes, a picture is emerging of how syrin-
gomycin pores function and are formed (118). Shortly after
insertion into the lipid bilayer, monomers of syringomycin ag-
gregate into pore complexes. Based on the voltage-dependent
behavior of ion channels, Feigin et al. (71) concluded that the
channel was formed by at least six molecules of syringomycin.
The lipophilic portion of each toxin subunit resides in the core
of the bilayer, and the hydrophilic peptide head resides close to
the surface of the membrane. Individual channels can become
aggregated into clusters that exhibit synchronous opening and
closing (118). The channel radius is approximately 1 nm for a
syringomycin pore (105, 118). This is comparable in size to the
channel dimensions of transmembrane pores formed by tola-
asin, a lipodepsipeptide produced by the mushroom pathogen
Pseudomonas tolaasii (211), and alpha-hemolysin, a cytolytic
protein produced by E. coli (30).
It appears that sterols influence channel formation by syrin-
gomycin but are not components of the channel structure (70).
Julmanop et al. (112) and Taguchi et al. (256) reported that
sterols, particularly ergosterol, promoted the binding of syrin-
gomycin to cells. Because sterols can play a significant role in
channel formation and are known to be essential for the cyto-
toxic activity of many pore-forming cytotoxins, such as strep-
tolysin O (62), and lipopeptides, such as iturin A (132), an
analogous role for sterols was proposed in channel formation
by syringomycin. However, Feigin et al. (71) showed that the
toxin readily formed ion channels in artificial membrane bilay-
ers that lacked sterols. Subsequently, Feigin et al. (70) dem-
onstrated that the addition of 50 mol% of ergosterol, stigmas-
terol, or cholesterol (sterols abundant in fungal, plant, and
animal cells, respectively) to bilayers failed to alter the channel
conductance properties of syringomycin.
The syringomycin pores are freely permeable to a series of
monovalent and divalent cations (105). Based on studies by
Takemoto and associates (215, 216, 293), an influx of H1
appears to be accompanied by an efflux of K1 across the
syringomycin channel. This K1-H1 exchange generates an
electrochemical gradient and collapses the pH gradient of the
plasma membrane, resulting in acidification of the cytoplasm.
The most conspicuous effect of channel formation by syringo-
mycin is a rapid and sustained influx of Ca21 ions that activates
a cascade of events associated with cellular signaling in plants
(120, 259, 260). For example, cytoplasmic influxes of Ca21
caused by low concentrations of syringomycin lead to induction
of kinase-mediated phosphorylation of membrane proteins
(32) and the incorporation of 1,3-b-callose into plant cell walls
(120). Consequently, the phosphorylation of a proton pump
ATPase, as observed by Bidwai and Takemoto (32), appears to
result from activation of protein kinases as modulated by a free
Ca21 signal (119). A short-term stimulation of the plasma
membrane ATPase occurs (33). The resultant increase in ATP
hydrolysis promotes the pumping of H1 and Ca21 back out
into the extracellular space, which in the long-term is ineffec-
tive against the collapse of the cation gradients of the cell. The
ultimate benefit to the bacterium from pore formation is the
systematic release of nutrients into the intercellular spaces of
host tissues (105) and the alkalization of intercellular fluids,
resulting in a more favorable environment for bacterial growth
(42).
Sphingolipids, which are major lipid components of eukary-
otic plasma membranes, have been associated with cell sensi-
tivity to syringomycin (45, 90). A SYR2 mutant of the fungus
Saccharomyces cerevisiae is highly resistant to syringomycin due
to a failure to produce 4-hydroxylated sphingolipids such as
phytoceramide (90). The total sphingolipid content of a SYR2
mutant is unchanged from the wild-type strain, and the mutant
exhibited an abundance of ceramide moieties containing only
dihydrosphingosine but not phytosphingosine. The significance
of these observations on the biological activity of syringomycin
is unclear, but sphingolipids play important roles in signal
transduction as mediators of growth suppression and pro-
grammed cell death (185).
Another feature of the amphipathic syringomycin molecule
is that it exhibits potent biosurfactant activity capable of low-
ering the interfacial tension of water to 31 mN/m, compared to
a value of 73 mN/m for HPLC-grade water (105). Although
pure preparations of syringomycin have a critical micelle con-
centration of 1.2 mg/ml, the surfactant properties are apparent
at much lower concentrations. The surface-active properties of
syringomycin are similar to those of other biosurfactants pro-
duced by fluorescent pseudomonads, including viscosin (183)
and tolaasin (104). Biosurfactant activity appears to play an
important role in spread of the bacterium across plant surfaces
by reducing the surface tension of water and by concentrating
relatively sparse nutrients at solvent interfaces (105).
Besides being phytotoxic, syringomycin and related lipo-
depsinonapeptides exhibit fungicidal activity toward a broad
spectrum of filamentous fungi, such as Geotrichum candidum,
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and yeasts, such as Rhodotorula pilimanae (133, 245). Accord-
ingly, assays for antifungal activity are conveniently used in
bioassays of the toxins, which are active at concentrations as
low as 0.8 mg/ml against yeasts (245). The related lipodepsi-
nonapeptides syringotoxin and syringostatin have nearly equiv-
alent broad-spectrum antifungal activity. Syringomycin also ly-
ses erythrocytes, but 10-fold-higher concentrations of the toxin
(i.e., 0.75 mg/ml) are required for comparable activity, as ob-
served in assays of tobacco protoplasts (103, 105). Recently,
efforts have been made to capitalize on the potent antifungal
activities of syringomycin to control clinically important fungi,
such as Candida spp. (245), and postharvest fungal pathogens
of citrus, such as Penicillium digitatum (38). However, the
strong hemolytic activity of syringomycin and related lipodep-
sinonapeptides remains a serious obstacle to commercial de-
velopment.
Biosynthesis of Syringomycin Occurs by a Nonribosomal
Mechanism of Peptide Synthesis
Syringomycin biosynthesis occurs on a multifunctional com-
plex of enzymes by a thiotemplate mechanism as originally
described for peptide antibiotics produced by Bacillus, Strep-
tomyces, and filamentous fungi (126). The first evidence for a
nonribosomal mechanism of toxin synthesis originated with the
association of large proteins, 470 kDa or larger, with lipodepsi-
nonapeptide production (179, 288). Nontoxigenic (Tox2) mu-
tants were identified that were altered in the formation of
these large proteins, which were speculated to function as
peptide synthetases. Another important milestone was the res-
olution of the cyclic lipodepsipeptide structure of syringomycin
containing nonproteinogenic amino acids and D-amino acids
(77, 240). The occurrence of these unusual amino acids in the
syringomycin peptide chain is indicative of nonribosomal mul-
tifunctional synthetases that catalyze the formation of peptides
that contain modified amino acids (126, 252). Subsequently,
Grgurina and Mariotti (89) used 14C-labeled amino acids to
determine that L-threonine is the precursor of both 2,3-dehy-
droaminobutyric acid and 4-chlorothreonine and that aspartic
acid was incorporated into 2,4-diaminobutyric and 3-hydrox-
yaspartic acids. The 3-hydroxy fatty acid tail of syringomycin
appears to be derived from 3-hydroxyalkanoates that are ac-
cumulated in fluorescent pseudomonads and utilized as carbon
and energy reserves (67).
Molecular genetic evidence for a thiotemplate mechanism of
syringomycin synthesis came from analysis of the syrB1 gene
that encodes an amino acid activation module characteristic of
peptide synthetases (291). The SyrB1 amino acid sequence
revealed six core sequences typical of the amino acid-activating
modules described previously (247) (Fig. 1B). The core se-
quences of SyrB1 exhibited the characteristic order and spac-
ing of thioester-forming modules involved in the synthesis of
gramicidin S and other peptide antibiotics (291). Recent bio-
chemical analysis demonstrated that the amino acid-activating
module of SyrB1 catalyzes the recognition and activation of
L-threonine (95). Thus, the syringomycin multienzyme system
represents one of the first described for Pseudomonas, al-
though it appears that all fluorescent pseudomonads synthesize
peptide-containing metabolites, such as pyoverdin (154), by
the thiotemplate mechanism.
Organization of the Syringomycin Gene Cluster Encoding
Peptide Synthetases
The syringomycin (syr) gene cluster encompasses a DNA
region of approximately 37 kb on the chromosome of P. syrin-
gae pv. syringae B301D (Fig. 8). Six ORFs in the syr gene
cluster are predicted to encode proteins involved in the syn-
thesis (syrB1, syrB2, syrC, and syrE) (95, 291), secretion (syrD)
(209), and regulation (syrP) (292) of syringomycin. The most
FIG. 8. Physical map of the syringomycin gene cluster of P. syringae pv. syringae compared to that of the surfactin gene cluster of B. subtilis. The amino
acid-adenylating domains and 49-phosphopantetheine carrier domains are indicated by cross-hatched and stippled regions, respectively, for each module. The small
circles attached above the proteins indicate the regions carrying motifs characteristic of thioesterases. The 37-kb syr gene cluster encodes four proteins (SyrB1, SyrB2,
SyrC, and SyrE) involved in biosynthesis. The syrD and syrP genes encode proteins predicted to be involved in secretion and regulation, respectively. The 31-kb srf gene
cluster encodes five proteins (SrfA-A, SrfA-B, SrfA-C, SrfA-TE, and Sfp) involved in surfactin synthesis. The sfp gene product has been proposed to function as a
49-phosphopantetheine transferase (147). The functions of the products of orf5 through orf8 are unknown.
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striking feature of the syr gene cluster is the presence of an
enormous (28.4-kb) ORF, designated syrE (95). Sequence
analysis indicated that syrE encodes a 1,039-kDa synthetase
containing eight amino acid activation modules (95). Thus,
SyrE represents the largest protein reported for a prokaryote
to date. Precedence for the formation of large synthetases
exists in the fungus Tolypocladium niveum, where the simA
gene encodes a 1,689-kDa synthetase involved in cyclosporin A
synthesis (281).
The domain organization of the predicted SyrE synthetase is
illustrated in Fig. 8; each amino acid activation module con-
tains domains for elongation, adenylation, and thiolation. The
various SyrE adenylation domains exhibit a high degree of
identity ranging from 45 to over 90%. Because the adenylation
domain harbors the regions responsible for amino acid recog-
nition and activation (247), the E1 adenylation domain of syrE
was amplified, cloned, overexpressed, and used in biochemical
assays (95). The E1 adenylation domain recognized L-serine as
a substrate in ATP-pyrophosphate (PPi) exchange reactions,
indicating that syringomycin synthesis is initiated by activating
the N-terminal amino acid, L-serine. The adenylation domain
of E1 is preceded by an elongation domain, which is presumed
to catalyze the acyl transfer of the 3-hydroxy fatty acid from
SyrC to L-Ser bound to E1 as a thioester (54, 252). Elongation
domains were previously shown to precede the first amino acid
activation domain in SrfA-A which initiates the synthesis of the
lipopeptide surfactin (252).
A distinctive structural feature of the SyrE synthetase is the
fusion of a TE domain to the last amino acid activation mod-
ule, E8 (Fig. 8) (95). This domain contains the GxSxG motif
characteristic of TEs involved in the synthesis of fatty acids,
polyketides, and peptide antibiotics (252). All bacterial peptide
synthetases exhibit a TE domain at the C-terminal end of the
synthetase that carries the last amino acid activation module;
the TE domain presumably catalyzes a termination reaction in
which the thioesterified peptide is released by hydrolytic cleav-
age from the synthetase. The importance of the TE domain in
peptide antibiotic production in bacteria was demonstrated by
Schneider and Marahiel (237); these researchers deleted the
TE region of srfA to srfC, which encodes the last synthetase in
surfactin synthesis, and reported a large reduction in surfactin
yield. Unique to SyrE is the positioning of the TE domain
relative to the E8 module, which are separated by intervening
elongation and thiolation domains (95). In effect, the C termi-
nus of SyrE contains elements of a ninth module that lacks an
adenylation domain.
The ninth adenylation domain appears to be encoded by
syrB (291). It is now known that syrB represents an operon that
expresses two proteins (290): the 68-kDa SyrB1 protein carry-
ing adenylation and thiolation domains, and the 35-kDa SyrB2
protein homologous to the CmaB protein in the COR gene
cluster (37). The substrate specificity of the overproduced
SyrB1 adenylation domain was analyzed in ATP-PPi exchange
reactions (95). SyrB1 activated L-threonine in exchange reac-
tions, whereas a series of amino acids including L-serine and
4-chlorothreonine were not recognized as substrates. There-
fore, SyrB1 presumably activates and binds L-threonine as a
thioester, which may be subsequently modified to yield 4-chlo-
rothreonine prior to transfer to the SyrE synthetase. Although
the function of SyrB2 in syringomycin synthesis is unknown,
one can speculate that it functions in the modification of L-
threonine bound to the SyrB1 thiolation domain or in the
cyclization of the mature peptide.
The syrC gene is located between the syrB operon and syrE
and encodes an enzyme with TE activity (Fig. 8) (291). SyrC is
similar to several proteins containing TE motifs, including
CmaT, which is presumed to function as a coronamic acid
thioesterase (270). The 48-kDa SyrC protein contains a Gx-
CxG motif with a Cys substituted for Ser as the active site, a
change that does not significantly affect the catalytic activity of
TEs (285). The TE activity of SyrC was demonstrated by Grgu-
rina et al. (87), who overproduced SyrC as an N-terminal
His-Tag fusion protein in E. coli. SyrC catalyzed the hydrolysis
of CoA from a 3-hydroxydodecanoyl-CoA substrate, support-
ing the hypothesis that SyrC functions as a thioesterase in
syringomycin biosynthesis with a potential role in acyltransfer
of a 3-hydroxy fatty acid. SyrC recognized a series of linear
long chain acyl-CoA derivatives as substrates but did not utilize
medium- or short-chain fatty acid derivatives. Site-directed
mutagenesis of syrC was used to generate Cys-to-Gly mutations
within the TE motif of SyrC, resulting in a mutant SyrC which
lacked TE activity (290). Thus, it appears that SyrC catalyzes
the transfer of the 3-hydroxydodecanoyl moiety from the cor-
responding CoA derivative to the amino group of serine bound
to the E1 module of SyrE (Fig. 8).
In summary, syringomycin synthesis is catalyzed by four pro-
teins, namely, SyrB1, SyrB2, SyrC, and SyrE (Fig. 8). In com-
parison, the surfactin gene cluster contains synthetases carry-
ing seven amino acid activation modules (Fig. 8) (247). The
adenylation of the N-terminal serine and covalent attachment
of the amino acid to the synthetase by a carboxyl thioester
initiate the biosynthetic process on the E1 module of SyrE
(Fig. 1B) (95). Within the adenylation domain of E1, a serine-
specific pocket located between core 2 and core 4 (47, 291)
recognizes L-serine. ATP is bound to core 2 and subsequently
cleaved by an ATPase located at core 4, leading to the forma-
tion of serine adenylate. The activated serine is then trans-
ferred to the thiolation domain and covalently linked by a
thioester bond to the cofactor, 49-phosphopantetheine, at a
conserved serine residue within core 6 (247, 252). The TE
activity of SyrC catalyzes the hydrolysis of 3-hydroxydode-
canoyl-CoA and may transfer the 3-hydroxy fatty acid to the
amino group of serine bound to the E1 module, thus forming
a 3-hydroxydodecanoyl-L-serine conjugate. The intermediate is
transferred to the E2 module, where the second amino acid,
D-serine, is covalently bound as a thioester to 49-phospho-
pantetheine. Each SyrE module carries a molecule of 49-phos-
phopantetheine covalently bound to the thiolation domain,
and this mediates the sequential transfer of carboxyl thioester-
activated amino acids between aligned modules (253). Synthe-
sis continues with a series of elongation cycles until an octapep-
tide is synthesized and bound at the thiolation domain of the
E8 module of SyrE. At this point, the adenylation domain of
SyrB1 interacts with the E8 module to incorporate the last
amino acid, L-threonine, which is ultimately modified as
4-chlorothreonine. The TE domain at the C terminus of SyrE
is presumed to release the mature syringomycin product from
the synthetase. SyrB2 is speculated to function either in mod-
ifying L-threonine bound to SyrB2 or in cyclization of the
mature peptide to form a lactone ring. Once cyclized, syringo-
mycin is exported across the cytoplasmic membrane by the
ATP-binding cassette (ABC) transporter protein, SyrD (209).
Regulation of Syringomycin Production
The regulation of syringomycin production is complex,
based on evidence that both nutritional factors and plant signal
molecules modulate toxin production by P. syringae pv. syrin-
gae (92). Iron exerts a positive regulatory effect on syringomy-
cin production based on evidence that Fe31 concentrations of
2 mM or higher are required for expression of a syrB-lacZ
transcriptional fusion (174) and for maximum yields of toxin by
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strain B301D (91). In contrast, syringomycin production is
repressed by inorganic phosphate concentrations of 1 mM or
higher (91), and this resembles the phosphate-mediated down-
regulation of antibiotic biosynthesis genes in many bacteria
(139). The discovery that specific plant signal molecules also
play a significant role in activating syrB gene expression and
syringomycin production (discussed below) demonstrates that
diverse environmental factors control the expression of genes
dedicated to toxigenesis in P. syringae pv. syringae. Unfortu-
nately, little is known about the complex genetic network re-
sponsible for the perception and transduction of these signals
to the syr transcriptional apparatus.
Toxin gene clusters encoding a multienzyme system of pep-
tide synthesis commonly carry regulatory elements that directly
control the expression of biosynthesis genes (126). Surpris-
ingly, the 37-kb syr cluster contains only one gene, syrP, that
exerts regulatory effects on syringomycin production (292). A
syrP mutant has an unusual pleiotropic phenotype with respect
to syringomycin production and is substantially reduced in
virulence on immature cherry fruits. In particular, syringomy-
cin production by a syrP mutant is relatively insensitive to high
inorganic phosphate concentrations in agar media. The syrP
gene is located between the syrB and syrD genes (Fig. 8) and
encodes a 40-kDa protein that may function in a phosphorelay
signal transduction pathway. The SyrP protein exhibits similar-
ity to the phosphoacceptor/transfer regions of histidine kinases
such as CheA (296) and KinA (204), which are regulatory
elements in phosphorelay pathways (7). Thus, SyrP may func-
tion in a phosphorelay system as an intermediate phosphate
transmitter between a sensor protein and a response regulator
(292). Phosphorelays govern major developmental commit-
ments in microorganisms, and an important advantage of phos-
phorelays is that multiple signals can be integrated at interme-
diate steps in the regulatory network (7). Nevertheless, a role
for SyrP in a phosphorelay mechanism of toxin production
remains speculative until other members of such a regulatory
system are identified and characterized. It is unclear whether
additional regulatory genes are located within the right border
region of the syr cluster (i.e., downstream of syrE) or are linked
to the syringopeptin gene cluster (Fig. 8).
Global regulators of syringomycin production which are not
physically linked to the syr cluster have been identified (101,
219). The gacS (lemA) and gacA genes encode members of a
two-component sensory transduction system in P. syringae pv.
syringae that regulates toxigenesis and the ability to cause
necrotic lesions in plants. Sequence analysis indicated that
GacS is a transmembrane protein which presumably functions
as a histidine protein kinase that undergoes phosphorylation in
response to environmental stimuli (101). GacA is a response
regulator protein that is presumably phosphorylated by GacS
(219). Like other members of the FixJ subclass of response
regulators (41), GacA carries the phosphorylation site at the N
terminus and a H-T-H motif at the C terminus (219). Never-
theless, it has not been demonstrated that GacS interacts di-
rectly with GacA to facilitate phosphate transfer in a two-
component signal transduction system. An unusual feature of
the gacS-gacA two-component system is that the two genes are
not physically linked. Furthermore, the GacS-GacA homologs
are conserved in fluorescent pseudomonads and control the
expression of a diversity of cellular functions including produc-
tion of protease, pectate lyase, pigments, and various antifun-
gal metabolites (78, 125).
The GacS-GacA protein pair appears to be at the top of the
regulatory hierarchy controlling syringomycin production, and
little is known about the intermediary regulators. Kitten et al.
(125) identified salA as a member of the gacS-gacA regulon
that can restore syringomycin production to a gacS mutant if
salA is overexpressed. A salA mutant is phenotypically distin-
guished from gacS or gacA mutants by a lack of suppression of
protease production. Correspondingly, expression of a syrB-
lacZ reporter was reduced to less than 3% in a salA mutant.
The predicted SalA protein sequence exhibits an H-T-H DNA-
binding motif with similarity to response regulators such as
FixJ (5). It remains to be determined if SalA, as a putative
response regulator, binds directly to the promoter region of the
syrB operon or, rather, activates the syrB operon indirectly
through one or more intermediary regulators such as SyrP.
Thus, it appears that salA, as an element in the gacS-gacA
regulon, controls the expression of the pathway that leads to
syringomycin production and formation of necrotic lesions in
plants (125). The gacS-gacA regulon also controls the expres-
sion of the ahlIPss gene specifying the synthesis of N-acylho-
moserine lactone by P. syringae pv. syringae (61). However,
syringomycin production is not controlled by the N-acylhomo-
serine lactone quorum-sensing signal. The environmental sig-
nals that activate the gacS-gacA regulon have not been identi-
fied, although they do not appear to be phenolic plant signal
molecules such as arbutin (175, 219).
The syrA gene identified by Xu and Gross (288) appears to
encode a regulatory protein required for syringomycin produc-
tion and pathogenicity. The syrA gene, which lies outside the
syr gene cluster, has not been sequenced, and its position in the
regulatory network controlling toxigenesis remains to be de-
termined.
Activation of Syringomycin Production by Plant
Signal Molecules
Phytotoxin production by P. syringae pv. syringae is modu-
lated by the perception of signals in the plant environment.
The primary signals are specific phenolic glycosides that are
abundant in the leaves, bark, and flowers of many plant species
parasitized by P. syringae pv. syringae (175). For example, ar-
butin (Fig. 9) is a phenolic b-glucoside distributed to more
than 10 dicot families; in pear (Pyrus communis), arbutin con-
stitutes 3 to 5% of the leaf material (156). In cherry (Prunus
avium) leaves, two flavonol glycosides (quercetin 3-rutinosyl-
49-glucoside and kaempferol 3-rutinosyl-49-glucoside) and one
flavanone (dihydrowogonin 7-glucoside) glycoside (Fig. 9)
have been identified as signal molecules based on the induction
of a syrB-lacZ fusion as a reporter of gene activity (173). The
plant signal molecules that activate toxin production by P.
syringae pv. syringae are chemically distinct from those that
activate the vir genes of Agrobacterium tumefaciens and the nod
genes of rhizobia (152, 205). An intact glucosidic linkage is a
structural feature of all syrB-inducing phenolic signal mole-
cules; plants accumulate and store phenolic compounds as
glycosides, which are more water soluble and less chemically
reactive (100). The flavonoid signal molecules from cherry are
equivalent in syrB-inducing activity and are abundant, as evi-
denced by the recovery of more than 11 mg (dry weight) of
dihydrowogonin 7-glucoside per g from phloem (264).
Phenolic signal activity is markedly enhanced in the pres-
ence of sugars that occur in large quantities in leaf tissue (173,
175). Sucrose and D-fructose are the most active sugars, caus-
ing a 10-fold stimulation of signal activity when phenolic sig-
nals occur at low concentrations. These two sugars also exhibit
intrinsic low-level syrB-inducing signal activity in the absence
of the phenolic inducer. Cherry contains an abundance of
sucrose and fructose based on estimates of more than 3% of
the dry weight of various tissues (121, 236). Consequently, the
concentrations of both sugars exceed the threshold of 10 ppm
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required for significant induction of the syrB operon (175). The
mechanism by which sugars augment the sensitivity of P. syrin-
gae pv. syringae to the phenolic signal is unknown. In A. tume-
faciens, the ChvE sensory system mediates enhanced induction
of vir genes (40). However, the two plant-microbe systems
differ in sugar specificity, with the most conspicuous distinction
being the inability of sucrose and D-fructose to enhance vir
gene induction in the presence of the phenolic signal acetosy-
ringone (4, 242).
In addition to the specific activation of syrB, the entire sy-
ringomycin biosynthetic apparatus is stimulated by plant sig-
nals in nearly all strains of the bacterium. The stimulatory
effect of plant signal molecules on syringomycin was quite
evident for some strains of P. syringae pv. syringae based on the
recovery of up to 10-fold-higher toxin yields in a defined me-
dium supplemented with arbutin and D-fructose (208). Fur-
thermore, some strains required plant signal molecules for the
production of syringomycin. In strains producing syringotoxin
or syringostatin instead of syringomycin, plant signal molecules
also stimulated toxigenesis. Such a network of communication
between the plant and the bacterium that controls toxigenesis
reflects the ability of P. syringae pv. syringae to adapt to a
dynamic plant environment. The sensory mechanism favors the
bacterium by detecting specific phenolic glycosides that signal
the bacterium to rapidly activate virulence genes. P. syringae
pv. syringae aggressively attacks a wide range of plants, and it
would not be surprising to find that all host plants contain
phenolics with the fundamental chemical structures responsi-
ble for signal activity.
SYRINGOPEPTIN
Syringopeptins represent a second class of lipodepsipeptide
phytotoxins produced by strains of P. syringae pv. syringae (9).
In contrast to lipodepsinonapeptides, syringopeptins contain
either 22 or 25 amino acids depending on the specific bacterial
strain (Fig. 10). The N-terminal amino acid, 2,3-dehydro-2-
aminobutyric acid, is acylated by either 3-hydroxydecanoic or
3-hydroxydodecanoic acid. An ester bond between allothreo-
nine and the C-terminal tyrosine residue forms a lactone ring.
A high percentage of hydrophobic amino acids are found in
syringopeptin, and Ballio et al. (11) determined that D-amino
acids compose most of the syringopeptin peptide chain. The
octapeptide cationic loop formed by a lactone ring, together
with the hydrophobic tail, is predicted to function as a mem-
brane-permeabilizing motif critical to biological activity (11).
Analysis of syringopeptins from several strains of P. syringae
pv. syringae demonstrated diversity in the peptide sequences of
syringopeptins (9, 110). For example, a strain of P. syringae pv.
syringae isolated from laurel produced Phe25-syringopeptin
25A with phenylalanine as the C-terminal amino acid instead
of tyrosine (232).
Cytotoxic Pore-Forming Activity
Syringopeptin exhibits extraordinary similarity to syringomy-
cin in phytotoxic activity. Iacobellis et al. (107) first described
the ability of syringopeptin to cause electrolyte leakage of plant
cells, which leads to the development of necrotic symptoms.
Subsequently, syringopeptin SP22A was shown to alter the
distribution of H1 across the plasma membrane of maize (57)
and promote stomatal closure in detached leaves of Xanthium
strumarium due to a rapid K1 efflux (58). Thus, syringopeptin
appears to induce an H1-K1 exchange response in plant cells
analogous to that induced by syringomycin (182).
The phytotoxic activity of syringopeptin is centered on an
ability to form pores in plant plasma membranes, thereby pro-
moting transmembrane ion flux and cell death. As a pore-
forming lipodepsipeptide, syringopeptin is able to form ion
channels in black-lipid membranes, to lyse both tobacco pro-
toplasts and erythrocytes, and to generate a rapid and sus-
tained influx of 45Ca21 across the plasma membrane of to-
bacco protoplasts (103). For example, the extreme sensitivity
of tobacco protoplasts was observed at syringopeptin concen-
trations as low as 100 ng/ml, at which about half of the proto-
FIG. 9. Structures of phenolic plant signal molecules known to activate the
syrB gene involved in syringomycin biosynthesis by P. syringae pv. syringae.
Arbutin is found in several plant species including pear (Pyrus communis L.). The
flavonol glycosides (quercetin 3-rutinosyl-49-glucoside and kaempferol 3-rutino-
syl-49-glucoside) and the flavanone glucoside (dihydrowogonin 7-glucoside) are
abundant in the leaves of sweet cherry (Prunus avium L.).
VOL. 63, 1999 PSEUDOMONAS SYRINGAE PHYTOTOXINS 279
plasts lysed after a 30-min incubation. Pores formed by syrin-
gopeptin in protoplasts are highly permeable to cations such as
Ca21, with an uptake rate between 0.6 to 0.8 nCi of 45Ca21
min/ml at a toxin concentration of 500 ng/ml. Both SP22A and
SP22B exhibited equivalent pore-forming activities despite dif-
ferences in the length of the hydrophobic 3-hydroxy fatty acid
tail. In direct comparisons of the cytotoxic activities of syrin-
gopeptin and syringomycin, both caused lysis of tobacco pro-
toplasts and 45Ca21 uptake at threshold concentrations of 50
ng/ml; erythrocytes were lysed at threshold toxin concentra-
tions between 0.75 to 1 mg/ml. Thus, on a molar basis, syrin-
gopeptin is more active in cytotoxic assays than syringomycin,
reflecting the much larger size of the syringopeptin molecule
and a concomitant increase in pore formation. Other studies
reported syringopeptin to be several times more active than
syringomycin in causing necrosis and electrolyte leakage in
plant tissues (107, 133) and in affecting stomatal conductance
in X. strumarium leaves (58). Although Hutchison and Gross
(103) found both toxins roughly equivalent in toxicity to to-
bacco protoplasts at 0.04 mM, whole tissues treated with toxin
concentrations of 0.4 mM or higher showed syringopeptin to be
more phytotoxic than syringopeptin (133).
The biophysical characteristics of syringopeptin pores have
not been studied, although it is predicted that aggregates of
syringopeptin monomers are required for pore formation in
lipid bilayers (103). Fewer molecules of syringopeptin may be
required to form a functional pore, because it has a larger
charged head than syringomycin. The two lipopeptide toxins
may interact synergistically in the plant-pathogen interaction
(107), but there is no evidence that pores composed of a
chimera of syringopeptin and syringomycin are formed (103).
Syringopeptin displays strong biosurfactant activity based on
the ability of SP22A and SP22B to lower the interfacial tension
of water to approximately 35 mN/m at concentrations of $10
mg/ml (103). Syringopeptin has a lower critical micelle concen-
tration than syringomycin does (i.e., 0.8 mg/ml for SP22B and
1.25 mg/ml for syringomycin form SRE). By reducing the con-
tact angle of water, syringopeptin together with syringomycin
may facilitate the spread of P. syringae on plant surfaces. The
amount of toxin produced in the plant environment is un-
known, but a typical strain of P. syringae pv. syringae has the
capacity to produce abundant quantities of the two lipodep-
sipeptides in vitro. For example, strain B301D produces 5 to 15
mg of both toxins per ml in vitro (103, 105) and plant signal
molecules stimulate toxin production in most strains of the
bacterium (173, 208).
Syringopeptin has antimicrobial activity against certain
gram-positive bacteria and fungi. Interestingly, syringopeptin
has an antimicrobial spectrum of activity distinct from that of
syringomycin and related lipodepsinonapeptides (133). For ex-
ample, some strains of Botrytis cinerea are highly sensitive to
syringopeptin but resistant to syringomycin. In contrast, Geotri-
chum candidum is sensitive to syringomycin and resistant to
syringopeptin. Bacillus megaterium was the most sensitive to
syringopeptin of a wide spectrum of microorganisms assayed
by Lavermicocca et al. (133). Because B. megaterium is resis-
tant to syringomycin, this bacterium is used in routine bioas-
says of syringopeptin activity (88, 103). The distinct antimicro-
bial activities of the two classes of lipodepsipeptides are in
sharp contrast to the relatively similar pore-forming activities
for the toxins in assays of tobacco protoplasts, erythrocytes,
and artificial membrane bilayers (103). The biological basis for
these differences is unknown.
Biosynthesis and Genetic Organization
Syringopeptin is synthesized by multienzymatic peptide syn-
thetases distinct from those involved in syringomycin synthesis
(88). Because the isoform of syringopeptin produced by strain
B301D contains 22 amino acids (9), the syp gene cluster is
predicted to exceed 60 kb based on the size of known syn-
thetase domains (247, 252). Mapping and sequence analysis
have indicated that the syp gene cluster is located adjacent to
the syr gene cluster (95, 238). Although a comprehensive map
of the syp cluster is unavailable, a syp region encoding one or
more peptide synthetases lies downstream of syrD. For exam-
ple, the sypA ORF begins 138 bp from the 39 end of syrD and
is transcribed in the same direction as syrD (Fig. 8). The first
amino acid activation module encoded by sypA has the same
domain organization as the SyrE1 module (Fig. 1B). Strains
carrying a transposon insertion in sypA failed to produce sy-
ringopeptin and were unaffected in syringomycin production.
Regulation of Production
Syringopeptin is produced under the same set of culture
conditions as syringomycin (88), suggesting that synthesis of
both classes of toxins is activated by a common regulatory
system. Nevertheless, it is unknown if the gacS-gacA regulon
(219) and the syrP gene (293) that control syringomycin pro-
duction play a corresponding role in controlling syringopeptin
production. A more thorough analysis of the syr and syp gene
clusters is needed to identify other regulatory elements that
control the production of one or both lipopeptide toxins.
Common Mechanism of Secretion for Syringopeptin
and Syringomycin
The syrD gene (Fig. 8) encodes a member of the ABC
transporter family which functions in the export of cytotoxic or
proteolytic proteins that enhance virulence in prokaryotes
FIG. 10. Structures of syringopeptin forms SP22 and SP25. The fatty acid can be either 3-hydroxydecanoic or 3-hydroxydodecanoic acid. Abbreviations of
nonstandard amino acids: Dab, 2,4-diaminobutyric acid; Dhb, 2,3-dehydroaminobutyric acid; aThr, allothreonine. D-Amino acids are common in both SP22 (13 of 22
residues) and SP25 (15 of 25 residues). A P. syringae pv. syringae strain from laurel produces a form of SP25 that differs from the above structure by the replacement
of Phe with Tyr at the C terminus (232). Strain SC1 from sugarcane produces a form of SP22 that differs from the above structure by the replacement of Leu at amino
acid positions 4 and 7 and 2-aminodehydropropionic acid (dehydroalanine) at position 9 (110).
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(209). ABC transporter proteins have been associated with the
secretion of both nonribosomally (79, 178) and ribosomally
encoded peptide antibiotics (44), but SyrD is the first ABC
transporter protein to be implicated in secretion of a lipopep-
tide antibiotic. SyrD exhibits high similarity to PvdE, an ABC
transporter required for pyoverdin secretion in P. aeruginosa
(151). An ATP-binding pocket of SyrD is located in the hy-
drophilic C terminus and is cytoplasmic, whereas the largely
hydrophobic N terminus is predicted to reside in the inner
membrane. Consequently, SyrD functions as an ATP-driven
efflux pump for syringomycin secretion across the cytoplasmic
membrane. Grgurina et al. (88) showed that syrD mutants of
B301D fail to produce both syringomycin and syringopeptin,
suggesting that secretion of both lipodepsipeptides is linked in
P. syringae pv. syringae.
The highly efficient SyrD-mediated export system may ex-
plain the resistance of P. syringae pv. syringae to lipodepsipep-
tide toxins. Syringomycin is toxic to P. syringae at high concen-
trations (93), and so a deficiency in toxin export would be lethal
unless toxin biosynthesis is reduced. Accordingly, strains car-
rying mutations in the syrD gene do not accumulate the toxins,
and expression of a plasmid-borne syrB-lacZ reporter gene
fusion is reduced substantially (88, 209). An active efflux by
ABC transporter proteins is frequently the basis for autoresis-
tance to antibiotics produced by actinomycetes (153).
Relative Contribution of Syringopeptin and Syringomycin to
Virulence
All strains of P. syringae pv. syringae that have been analyzed
produce both classes of the lipodepsipeptide phytotoxins, and
this suggests interrelated roles for the toxins in the plant-
pathogen interaction. It is now recognized that both syringo-
mycin and syringopeptin are pore-forming cytotoxins that
cause necrosis in plants by similar mechanisms (103). The
advantages of producing two phytotoxic cytotoxins during
pathogenesis are unclear, but their contribution to virulence is
significant based on assays of mutants defective in the synthesis
of one or both types of lipopeptide toxins. For example, strains
carrying mutations in either the syrB1 gene, encoding a syrin-
gomycin synthetase, or the sypA gene, encoding a syringopep-
tin synthetase, exhibit a 35 to 50% reduction in virulence com-
pared to the wild-type strain in assays of immature cherry fruits
(209, 239). Strains carrying mutations in both syrB1 and sypA
showed the greatest reduction in virulence based on measure-
ments of lesion size in cherry fruits. The virulence of a syrB1-
sypA double mutant was roughly equivalent to that of the syrD
mutant BR105 (209) defective in secretion of both classes of
lipodepsipeptides (88). In contrast, a mutation in the syrB
operon of strain B728a pathogenic to bean was reported to
have no effect on virulence in bean pathogenicity tests (125).
Thus, the contribution of toxin production to virulence may
vary with the plant host parasitized by P. syringae pv. syringae.
TABTOXIN
Tabtoxin is a monocyclic b-lactam produced by P. syringae
pv. tabaci, coronafaciens, and garcae (163). The dipeptide
toxin contains tabtoxinine-b-lactam (TbL) linked by a peptide
bond to threonine (Fig. 11). Although tabtoxin is the primary
intracellular metabolite produced (64), the chlorosis-inducing
activity occurs only after hydrolysis of the peptide bond by
aminopeptidases of plant or bacterial origin (136, 269). Cleav-
age of the peptide bond in tabtoxin releases TbL, the toxic
moiety (136, 269).
Mode of Action
TbL irreversibly inhibits glutamine synthetase (263). The
inhibition of glutamine synthetase has at least two major ef-
fects; first, the enzyme is presumably the major route for glu-
tamine synthesis in plants, and second, the enzyme is the only
way to efficiently detoxify ammonia. A variety of harmful ef-
fects have been attributed to ammonia in plants, including
disruption of the thylakoid membrane of the chloroplast and
uncoupling of photophosphorylation (66, 267). Protection of
the bacteria from the toxin has been associated with the ad-
enylation of glutamine synthetase, which renders the target
enzyme less susceptible to inactivation by TbL (127). A second
potential detoxification mechanism involves the production of
b-lactamases which hydrolyze the b-lactam ring of TbL to
liberate the nontoxic metabolite, tabtoxinine (46, 128).
Genetic Aspects of Production
TbL is associated with the symptoms of wildfire disease on
tobacco and halo blight of oats but is considered to be a
virulence factor rather than an essential component of these
diseases (63). For example, P. syringae pv. angulata, which
induces necrotic spots on tobacco leaves without producing
chlorotic halos, is considered to be a spontaneous toxin-defi-
cient derivative of P. syringae pv. tabaci (124). Similarly, P.
syringae pv. striafaciens is thought to be a nontoxigenic deriv-
ative of P. syringae pv. coronafaciens, the causal agent of halo
blight of oats (284). The natural occurrence of tabtoxin-defec-
tive strains is caused by the instability of the tabtoxin biosyn-
thetic gene cluster, which excises from the chromosome at
fairly high frequencies (124, 268). Kinscherf et al. (124) showed
that a clone containing a 31-kb DNA fragment conferred tab-
toxin production to P. syringae BR2 and Cit7, suggesting that
all the genes necessary for tabtoxin synthesis in P. syringae were
clustered in this 31-kb region.
Biosynthesis and Regulation
The biosynthetic precursors of tabtoxin were identified by
the incorporation of 13C-labeled compounds and shown to
consist of L-threonine and L-aspartate for the side chain and
pyruvic acid and the methyl group of L-methionine for the
b-lactam moiety (222, 274). A biosynthetic model for the for-
mation of TbL resembles that of lysine, where the first dedi-
cated step is the DapA-catalyzed condensation of aspartic acid
semialdehyde with pyruvate to form L-2,3-dihydropicolinate
(DHDPA) (Fig. 12). The next step, the pyridine nucleotide-
linked reduction of DHDPA to L-2,3,4,5-tetrahydropicolinate
(THDPA), is catalyzed by DapB (Fig. 12). Previous studies
FIG. 11. Structure of tabtoxin, which consists of the toxic moiety, TbL, linked
via an amide bond to threonine. The arrow shows the site of aminopeptidase
cleavage, which releases TbL.
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have suggested that tabtoxin biosynthesis branches off from the
lysine biosynthetic pathway before the formation of diamin-
opimelate (DAP) (222, 274).
Engst and Shaw (69) identified a gene, tabA, which is essen-
tial for tabtoxin production. The discovery of this gene pro-
vided the first experimental data to support the hypotheses
that the precursors for tabtoxin originate from the lysine bio-
synthetic pathway. The deduced amino acid sequence of tabA
showed significant relatedness to lysA, which encodes DAP
decarboxylase in bacteria. Although tabA was not required for
lysine biosynthesis, Engst and Shaw (69) proposed that the
tabA translational product is an enzyme which recognizes a
substrate analogue of a compound in the biosynthetic route to
lysine. In a subsequent study, Liu and Shaw (141) showed that
dapB was required for both DAP and TbL synthesis. Their
results indicated that the most likely branch point of the lysine
and TbL pathways occurred after THDPA synthesis and be-
fore DAP formation (Fig. 12).
The deduced product of a tabB, also located in the TbL
biosynthetic region (140), showed relatedness to dapD (Fig.
12), a gene encoding THDPA succinyl-CoA succinyltrans-
ferase (THDPA-ST). Complementation studies and enzymatic
assays indicated that tabB encodes a product with THDPA-ST
activity. Liu and Shaw (140) proposed that TabB is an acetyl-
transferase that converts an unknown compound to an acetyl
derivative, which is further metabolized to TbL (Fig. 12). This
is consistent with the proposal of Feistner et al. (72) that
acetylated intermediates are involved in tabtoxin biosynthesis.
In summary, DapB is essential for both lysine and tabtoxin
biosynthesis and THDPA may be an intermediate in both
pathways. Three genes have been characterized in the 31-kb
region which contains all genes necessary for TbL synthesis
and tabtoxin resistance: tabA, tabB, and tblA (15, 69, 140).
Although there is no obvious relationship between TblA and
known polypeptides, TabA has significant sequence homology
to LysA from E. coli and P. aeruginosa whereas TabB shows
relatedness to DapD.
Some progress has been made on elucidating factors that
regulate tabtoxin biosynthesis in P. syringae. Durbin and
Uchytil (65) showed that production of TbL by P. syringae pv.
tabaci required the addition of zinc to the growth media. In a
subsequent study, zinc was shown to be required for the ami-
nopeptidase activity which hydrolyzes tabtoxin to release TbL
(136). Barta et al. (16) showed that tblA, a gene required for
tabtoxin synthesis, is regulated by the gacS (lemA) gene in P.
syringae pv. coronafaciens. As mentioned above, the gacS locus
was conserved among P. syringae pathovars and contained do-
mains that are characteristic of histidine protein kinases which
function as environmental sensors (101, 218).
PHASEOLOTOXIN
Phaseolotoxin is produced by P. syringae pv. phaseolicola
and actinidiae, which cause halo blight on legumes and bacte-
rial canker on kiwifruit, respectively (157, 230). The structure
of phaseolotoxin was elucidated by Mitchell (157), with minor
revision by Moore et al. (177), and consists of a sulfodiamin-
ophosphinyl moiety linked to a tripeptide consisting of orni-
thine, alanine, and homoarginine (Fig. 13A).
Mechanism of Action
Phaseolotoxin competitively inhibits ornithine carbamoyl
transferase (OCTase), a critical enzyme in the urea cycle which
converts ornithine and carbamoyl phosphate to citrulline (Fig.
14). Although phaseolotoxin is a reversible inhibitor of OC-
Tase, it is hydrolyzed in planta by peptidases to produce Nd-
(N9sulfodiaminophosphinyl)-L-ornithine, also called octicidine
or PSorn (Fig. 13B). Octicidine is an irreversible inhibitor of
OCTase and the predominant form of the toxin in infected
tissues (164). Inhibition of OCTase causes an accumulation of
ornithine and a deficiency in intracellular pools of arginine
(Fig. 14), leading to chlorosis. The urea cycle is a critical
pathway in both prokaryotes and eukaryotes, and P. syringae
pv. phaseolicola deals with the toxic effect of phaseolotoxin by
producing two isozymes of OCTase. One isozyme is resistant to
the toxin (ROCTase), and one is sensitive (SOCTase). During
conditions favorable to phaseolotoxin production, P. syringae
pv. phaseolicola synthesizes the ROCTase isoform (201, 251,
262).
FIG. 12. Biochemical pathways involved in the synthesis of lysine and TbL. In lysine biosynthesis, the first committed step is the DapA-catalyzed condensation of
aspartic acid semialdehyde with pyruvate to form DHDPA. DHDPA is then reduced to THDPA, a reaction catalyzed by DapB. Tabtoxin biosynthesis is thought to
diverge from the lysine biosynthetic pathway after THDPA synthesis and before DAP formation (vertical arrow). TabB is related to DapD, a gene encoding THDPA
succinyl-CoA succinyltransferase. TabB is thought to function as an acetyltransferase that converts an unknown compound (xTHDPA) to an acetyl derivative, which
is further metabolized to TbL.
FIG. 13. Structure of phaseolotoxin (A) and octicidine (B). Plant peptidases
cleave phaseolotoxin (arrow) to release the alanine and homoarginine residues,
a reaction which results in octicidine formation.
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Genetic Aspects of Production
The importance of phaseolotoxin in the virulence of P. sy-
ringae pv. phaseolicola was demonstrated in an early study by
Patil et al. (198), who showed that phaseolotoxin-defective
mutants did not move systemically in bean plants. Mutational
complementation has since been used to isolate genes involved
in phaseolotoxin production (200, 294). Peet et al. (200) re-
ported the first cloning of genes required for phaseolotoxin
biosynthesis on a cosmid clone designated pRCP17. In a later
study, pRCP17 was shown to contain the argK gene, which
encodes ROCTase (201). A 2.6-kb fragment from pRCP17
complemented several Tox2 mutants and was subsequently
used as a probe for detection of strains which produce phaseo-
lotoxin (233).
In an independent study, Zhang et al. (294) isolated a clone
designated pHK120 which contained a 25-kb insert and re-
stored phaseolotoxin production to Tox2 mutants. Pairwise
complementation analysis indicated that pHK120 contained a
minimum of eight transcriptional units designated phtA
through phtH. A comparison of the insert from pHK120 with
that from pRCP17 revealed that the inserts in these two cos-
mids overlap; pHK120 lacked the argK gene but included re-
gions missing from pRCP17 (294). Zhang and Patil (295) de-
termined the nucleotide sequence of the phtE locus, a region
transcribed as a 6.4-kb operon. Six ORFs were identified in the
phtE transcript, and three of these showed significant related-
ness to genes or motifs deposited in various databases. The
ORF3 amino acid sequence showed significant relatedness to
acetylornithine aminotransferase (ACOAT) and ornithine
aminotransferase (OAT) from various organisms. ACOAT
catalyzes the reversible conversion of N-acetylglutamate-5-
semialdehyde and glutamate to N2-acetylornithine and 2-oxo-
glutarate, whereas OAT catalyzes the transfer of the acetyl
group of N2-acetylornithine onto glutamate to yield ornithine
and N-acetylglutamate (50). These results suggest that ORF3
is involved in the production of ornithine, a constituent of
phaseolotoxin (295). ORF5 contained an H-T-H domain and a
putative leucine zipper, motifs which suggest a regulatory role
for ORF5 in phaseolotoxin production. The translational prod-
uct of ORF6 showed relatedness to a number of fatty acid
desaturases; these enzymes are known to generate unsaturated
fatty acids for the synthesis of phospholipids in the cytoplasmic
membrane (279). Independently, Hatziloukas et al. (97) se-
quenced the 2.6-kb fragment used for detection of P. syringae
pv. phaseolicola and showed that it contained a gene (desig-
nated ptx) related to fatty acid desaturases. Although several
differences were noted between the nucleotide sequence of
ORF6 and ptx, they appear to be the same gene. Hatziloukas et
al. (97) speculated that the fatty acid desaturase encoded by ptx
may facilitate the export of phaseolotoxin across the bacterial
membrane at the low temperatures conducive to phaseolotoxin
production.
Biosynthesis and Regulation
Biosynthetic precursors for the Nd-(N9sulfodiaminophosphi-
nyl) moiety of phaseolotoxin have not been identified.
Ma¨rkisch and Reuter (148) demonstrated that the homoargi-
nine and ornithine residues of phaseolotoxin are synthesized
by a transamidination reaction from arginine and lysine. The
amindinotransferase had an Mr of about 200,000 and showed
high substrate specificities for arginine and lysine in phaseolo-
toxin-producing strains of P. syringae pv. phaseolicola. Zhang
and Patil (295) suggested that the ORF3 product of the phtE
may catalyze the formation of the ornithine needed for phaseo-
lotoxin production, but biochemical evidence for this function
is lacking.
A nonribosomal, thiotemplate mechanism similar to that
used for the synthesis of peptide antibiotics is likely to be
required for biosynthesis of phaseolotoxin, since this molecule
contains a tripeptide moiety consisting of ornithine, alanine,
and homoarginine. As noted above, peptide synthetases con-
tain adenylation and thiolation domains consisting of con-
served core sequences with the same order and spacing (Fig.
1B and 8). Turgay et al. (265) synthesized degenerate primers
derived from the ATPase and thioester-forming domains
(cores 4 and 6, respectively). These degenerate primers were
used to amplify and clone a putative peptide synthetase from P.
syringae pv. phaseolicola. Although the involvement of this
region in phaseolotoxin synthesis has not yet been demon-
strated, this approach was previously used to isolate portions of
the surfactin synthetase from B. subtilis (35).
Temperature is a factor which regulates phaseolotoxin pro-
duction in P. syringae pv. phaseolicola. Goss (84) showed that
the chlorosis associated with P. syringae pv. phaseolicola infec-
tion of bean was induced at lower temperatures (18 to 20°C)
and absent at higher temperatures (28 to 32°C). Subsequent
studies showed that phaseolotoxin production decreased pro-
gressively at temperatures above 18°C (158, 184). Rowley et al.
(223) described the production of a repressor when P. syringae
pv. phaseolicola was grown at 28°C, a temperature unfavorable
for phaseolotoxin synthesis. Production of this repressor at the
nonpermissive temperature may explain the thermoregulation
of phaseolotoxin biosynthesis.
DETECTION OF PHYTOTOXINS AND TOXIN-
PRODUCING BACTERIA
Visual assessment of phytotoxin production in planta can be
somewhat subjective since there are a limited number of ways
in which plants react visibly to phytotoxins (stunting, chlorosis,
necrosis, and wilting). However, it should be emphasized that
studies of particular phytotoxins are probably influenced by the
visible evidence of their activity. Some phytotoxins may instead
act by changing metabolic processes in the host in such a way
that the deleterious activity might be manifested only at the
biochemical level.
FIG. 14. Mechanism of action of octicidine (PSorn), the toxic moiety of
phaseolotoxin. PSorn is an irreversible inhibitor of OCTase, a critical enzyme in
the urea cycle which converts ornithine and carbamoyl phosphate to citrulline.
Inhibition of OCTase causes an accumulation of ornithine and a deficiency in
intracellular pools of arginine, leading to chlorosis. Diagonal parallel lines indi-
cate the block in the urea cycle elicited by PSorn.
VOL. 63, 1999 PSEUDOMONAS SYRINGAE PHYTOTOXINS 283
When a toxic metabolite is suspected of contributing to
disease, extraction of the component from the producing or-
ganism is required. If the toxin is produced in vitro, the initial
purification may proceed from aqueous or organic phases of
the culture supernatant. Some knowledge of organic chemistry
is required at this juncture since the ultimate aim will be to
obtain or verify the structure of the toxin by mass spectrome-
try, nuclear magnetic resonance spectroscopy, or other analyt-
ical methods. Reproduction of some aspect of the disease (for
example, chlorosis or necrosis) by using the purified compound
is essential in proving the role of the phytotoxin in symptom
development.
As noted in the previous sections on individual phytotoxins,
molecular techniques have been used to construct Tox2 deriv-
atives of phytopathogenic bacteria. Mutational cloning has
been used successfully to recover genes required for phytotoxin
production, and Tox2 mutants have been used to assess the
contribution of phytotoxins to disease development and symp-
tomology (24, 124, 177, 200, 287, 294). A priori, it is necessary
to establish a reliable and simple method for detecting pro-
duction of the phytotoxin.
Bioassays for Toxins Produced by P. syringae
Some phytotoxins are antimicrobial and can be detected in
bioassays with sensitive fungi or bacteria. For example, phaseo-
lotoxin production can be detected at picogram levels by
growth inhibition of E. coli K-12 (250). Both Geotrichum can-
didum and Rhodotorula pilimanae are sensitive to syringomycin
and can be used in bioassays for this phytotoxin (93, 293). In
contrast, syringopeptin production is detected in bioassays with
Bacillus megaterium (133). Tabtoxin also has antimicrobial ac-
tivity and can be detected in bioassays with toxin-sensitive
bacteria or fungi (81). Although COR is not antimicrobial, it
can be detected by its ability to induce chlorosis in a variety of
plants; however, this assay is qualitative rather than quantita-
tive. Vo¨lksch et al. (277) have described a semiquantitative
bioassay for COR in which a hypertrophic reaction on potato
tissue is used to detect the toxin. Although this assay is sensi-
tive, some variability can occur depending on the potato cul-
tivar used and the age of the potato tissue.
Analytical Methods for Assessing Toxin Production
Quantitative chromatographic methods are available for de-
tecting COR (23), tabtoxin (15), and lipodepsipeptides, syrin-
gomycin, and syringopeptin (9). To facilitate genetic studies of
COR biosynthesis, a rapid extraction and fractionation method
for COR was developed which involves the direct extraction of
organic acids from 0.5 ml of culture supernatant, a 9-min
fractionation on a reverse-phase C8 column in a gradient of
acetonitrile and water, and quantitative detection at 208 nm
(189). The extraction can be performed in microcentrifuge
tubes and takes approximately 3 min, and HPLC fractionation
accurately separates and quantifies CFA, COR, coronafacoyl-
valine, and CFA-Ile. The availability of quantitative detection
methods for COR and the two defined intermediates in the
COR pathway (CFA and CMA) has greatly facilitated the
analysis of mutant phenotypes (21).
Molecular Detection of Phytotoxins and Toxin
Synthesis Genes
One outcome of the mutational cloning of toxin gene clus-
ters has been the development of DNA probes or PCR primers
for the identification of phytotoxin-producing strains of P. sy-
ringae. For example, a DNA probe containing the ptx gene was
used to detect and identify P. syringae pv. phaseolicola from
mixed cultures and diseased specimens (233). Oligonucleotide
primers derived from the DNA probe were sensitive enough to
detect P. syringae pv. phaseolicola in commercial seed lots
(234). Recently, PCR primers based on the sequence of the
gene encoding ROCTase, argK, were used for specific detec-
tion of P. syringae pv. phaseolicola and actinidiae (181, 230).
The PCR amplification procedure was applied directly to bac-
teria present in seed extracts and shown to be extremely sen-
sitive (181). Similarly, DNA probes and PCR primer sets from
the COR biosynthetic gene cluster have proven useful for the
detection of COR-producing pathovars of P. syringae (28, 53,
257).
The utility of toxin synthesis genes in strain identification
was further demonstrated by Quigley and Gross (208), who
used DNA probes containing syrB1 and syrD to show the con-
servation of these sequences among syringomycin-producing
strains of P. syringae. Scheck et al. (235) used the syrB1 and
syrD genes in combination with bioassays on lilac plantlets to
identify strains of P. syringae pv. syringae pathogenic on woody
ornamentals. More recently, Sorensen et al. used PCR to am-
plify a 752-bp fragment of syrB1 and successfully detected P.
syringae pv. syringae strains which produced syringotoxin and
syringostatin, cyclic lipodepsinonapeptide toxins related to sy-
ringomycin (246).
Although DNA probes and PCR primers have been ex-
tremely helpful in bacterial detection, they do not indicate
whether the phytotoxin is actively synthesized in vitro or in
planta. Although serological methods are more attractive for
this type of analysis, the phytotoxins discussed in this review
are too small to be antigenic and must be conjugated to a
carrier protein to form a hapten conjugate that is large enough
to generate antibodies. Leary et al. (135) reported on the use
of polyclonal antibodies to detect COR in vitro, suggesting that
an immunological approach could be used for COR detection.
More recently, Jones et al. (111) constructed a COR-ovalal-
bumin conjugate where COR was linked to ovalbumin at the
free carboxyl group present on CMA. This hapten conjugate
was used to produce monoclonal antibodies that were subse-
quently used in a competitive enzyme-linked immunosorbent
assay. One monoclonal line recognized COR and coronafa-
coylvaline equally well and CFA-Ile and CFA-aIle to a lesser
extent. Furthermore, the monoclonal antibody did not recog-
nize CFA or CMA, which are the nonphytotoxic intermediates
in the pathway to COR. Since COR-producing P. syringae
strains often synthesize coronafacoyl analogues (161, 165, 169),
this monoclonal antibody should be useful in detecting the
entire family of coronafacoyl phytotoxins.
ENGINEERING PLANTS WITH PHYTOTOXIN
RESISTANCE
Several novel strategies have been used to develop plants
with resistance to phytotoxins. When phytotoxins are broadly
antimicrobial, they are also frequently toxic to the producing
organism. Consequently, one potential source of toxin resis-
tance is the phytotoxin producer, P. syringae.
Transgenic Plants with Phaseolotoxin and Tabtoxin
Resistance
The cloning of the gene encoding ROCTase (argK) from P.
syringae pv. phaseolicola and its subsequent use as a transgene
have been successful in the development of phaseolotoxin-
resistant plants. As mentioned above, phaseolotoxin competi-
tively inhibits OCTase, which converts ornithine and car-
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bamoyl phosphate to citrulline (Fig. 14). The argK gene has
been cloned and sequenced (97, 180), and two laboratories
have used it as a source of phaseolotoxin resistance in tobacco
(55, 96). In plant cells, OCTase is produced in the chloroplast,
and so it was necessary to target the product of the argK gene
into the chloroplast. This was done by fusing the argK coding
region to the transit peptide of the small subunit of ribulose
bisphosphate carboxylase (Fig. 15) (55). This construct was
cloned into a plant transformation vector, introduced into A.
tumefaciens, and then transformed into tobacco leaf disks.
Rooted plants were then transplanted to soil and screened for
OCTase activity and phaseolotoxin sensitivity. Control tobacco
plants which contained SOCTase showed chlorosis in response
to phaseolotoxin treatment and had a reduced chlorophyll
content. Transgenic plants expressing ROCTase did not turn
chlorotic when treated with phaseolotoxin and had no change
in chlorophyll content. Control tobacco plants were systemi-
cally infected when inoculated with P. syringae pv. phaseolicola,
but the transgenic plants expressing ROCTase showed a local-
ized HR in response to infection. Therefore, a level of host
resistance to both the pathogen and the toxin was expressed in
the transgenic plants (55). The next challenge will be to intro-
duce argK into bean plants, the natural host for P. syringae pv.
phaseolicola.
As mentioned above, tabtoxin and TbL inhibit glutamine
synthetase; consequently, tabtoxin-producing strains of P. sy-
ringae must protect themselves from these compounds. Anzai
et al. (6) isolated a gene designated ttr (for “tabtoxin resis-
tance”), which conferred resistance to transgenic tobacco har-
boring this gene. Presumably, ttr functions to acetylate tabtoxin
and TbL, and the acetylated forms of these toxins are nontoxic
(6). Batchvarova et al. (18) reported that the resistance con-
ferred by ttr was heritable in transgenic tobacco. Other poten-
tial sources of resistance to tabtoxin include the b-lactamases
synthesized by the producing organism and the enzymes which
adenylate glutamate synthetase, rendering it resistant to tab-
toxin and TbL (46, 127, 128).
Selection for Coronatine Resistance in A. thaliana
Since the mode of action of COR is unclear, precise modi-
fication of the target site to render it resistant to the toxin is not
currently possible. Moreover, COR does not show antibiotic
activity to prokaryotic cells, so that COR producers do not
possess a resistance gene that could be used to develop trans-
genic plants with insensitivity to the toxin. However, one alter-
native strategy is to use mutagenesis to select COR-resistant
(Corr) plants and then identify the target site in the mutants by
map-based cloning. For example, the coi1 mutant of Arabidop-
sis thaliana was obtained by exposing seeds to mutagenic con-
centrations of ethyl methanesulfonate (75). The coi1 mutants
were insensitive to MeJA and resistant to P. syringae infection
(75). The wild-type allele (COI1) was recently localized by
mapped-based cloning, sequenced, and shown to contain
leucine-rich repeats and an F-box motif, which suggests that
the COI1 protein plays a role in protein-protein interactions
(286). Ultimately, COI1 and the identification of related genes
may facilitate the introduction of Corr into agronomically im-
portant host plants, such as tomato and soybean.
ENGINEERING NEW COMPOUNDS BY USING
PHYTOTOXIN GENES
It is now possible to take a genetic rather than synthetic
approach to biosynthesize novel peptides and polyketides with
altered biological properties. Much of the reprogramming or
engineering of novel peptides and polyketides has involved
actinomycete or fungal gene clusters, but much of this tech-
nology could also be applied to compounds synthesized by
Pseudomonas.
Peptide Synthetases
As mentioned previously, the nonribosomal synthesis of
peptides is catalyzed by using a protein template that contains
the correct number and order of activating units (126). This
knowledge has been used for the rational design of bioactive
peptides with altered biological properties. Marahiel’s group
(248, 249) was the first to successfully reprogram a peptide
synthetase to produce a novel peptide. These experiments in-
volved the srfA operon (Fig. 8), which encodes the biosynthesis
of surfactin in B. subtilis. The recombination was achieved by a
combination of gene disruption and replacement. The result
was the replacement of the Bacillus subtilis leucine domain
with the phenylalanine, ornithine, and leucine domains from
the grs operon of Bacillus brevis and the cysteine and valine
domains of the ACV synthetase from Penicillium chrysogenum
(248, 249). The surfactin derivatives produced by the engi-
neered Bacillus strains were characterized by infrared spectros-
copy and mass spectrometry and shown to contain the pre-
dicted amino acid substitutions. Furthermore, the genetically
modified surfactin derivatives retained biological activity.
These results are exciting because they indicate that amino
acid-activating domains from different organisms can be ex-
changed and used to produce novel compounds. Ultimately, it
should be possible to conduct similar experiments with Pseudo-
monas by using the alloisoleucine-activating domain encoded
by cmaA or one of the amino acid-activating domains encoded
by the syr or syp gene clusters.
Polyketide Synthases
Both type I and II PKSs have been exploited in the con-
struction of novel products via genetic engineering (59, 113–
115, 146, 149, 150, 186, 207, 224). One important innovation
was the development of a Streptomyces host-vector system
which facilitated the efficient construction and expression of
recombinant polyketides (150). The shuttle vector pRM5 con-
tained the minimal set of type II genes required for polyketide
synthesis but lacked the tailoring genes which diversify the
resulting product (150). The first hybrids to be constructed
contained various combinations of the actinorhodin, granati-
cin, and tetracenomycin gene clusters, and the majority of
recombinants generated novel polyketide products (150).
The Streptomyces coelicolor CH999(pRM5) expression sys-
tem proved immensely useful for analyzing the function of type
II PKS genes. However, the same system has also been used to
generate recombinant polyketides containing the type I eryA
genes. For example, overproduction of the DEBS 1 protein in
pRM5 resulted in the synthesis of a triketide lactone which was
FIG. 15. Construct used for obtaining transgenic tobacco with resistance to
phaseolotoxin. LB and RB indicate the left and right border regions, respectively,
of the T-DNA region in the Ti plasmid of Agrobacterium tumefaciens. The argK
gene encodes ROCTase, the toxin-resistant form of ornithine carbamoyltrans-
ferase. A transit peptide (tp) sequence was inserted at the 59 end of argK to
facilitate targeting of the gene product to the chloroplast. The argK gene was
expressed under control of the 35S promoter of CaMV. The neomycin trans-
ferase gene (NPTII) was used as a selective marker and expressed by using the
nos (nopaline synthetase) promoter. Arrowheads indicate the direction of tran-
scription. See reference 55 for additional details.
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the predicted product of modules 1 and 2 (114). The quantity
of this product increased when the TE domain located at the C
terminus of DEBS 3 was added to DEBS 1 (48, 115). Oliynyk
et al. (186) further utilized the pRM5 expression system in a
subsequent experiment where the acetyltransferase (AT) do-
main from module 1 of DEBS 1 was replaced with the AT from
module 2 of the rapamycin PKS. This experiment resulted in
the synthesis of two novel triketide lactones with the predicted
structures (186).
Although the reprogramming experiments discussed above
involve PKSs from gram-positive bacteria, exploitation of these
approaches has been extended to fungal PKSs. For example,
the fungal polyketide 6-methylsalicylic acid is synthesized by
6-methylsalicylic acid synthase, a multifunctional PKS. Bed-
ford et al. (20) expressed the 6-methylsalicylic acid synthase
genes in S. coelicolor CH999 and showed that the recombinant
strain produced significant amounts of 6-methylsalicylic acid.
These results are especially relevant to the potential expression
of Pseudomonas polyketides in heterologous hosts. The expres-
sion of selected multifunctional or monofunctional PKS genes
from the CFA region in pRM5 could be used to generate new
polyketides with altered biological activities. For example, the
starter unit for CFA synthesis is presumed to be a-ketogluta-
rate (194). The monofunctional proteins, Cfa1 to Cfa5, are
presumably involved in the conversion of the starter unit into
a cyclopentenone product, which is then loaded to Cfa6 (197).
Some of these genes could be exploited to engineer the incor-
poration of unique precursor molecules into existing polyke-
tides. Such changes might change or expand the biological
activity of the resulting polyketide product.
PERSPECTIVES
Our understanding of phytotoxin biosynthesis, regulation,
and mode of action has expanded largely due to multidisci-
plinary studies which integrate genetics, biochemistry, and or-
ganic chemistry. Additional work is clearly needed to define
the structural genes involved in the synthesis of tabtoxin,
phaseolotoxin, and syringopeptin. For COR and syringomycin,
biochemical studies to examine proposed gene functions based
on sequence analyses have been completed or are under way.
The results of these experiments will facilitate the develop-
ment or revision of models for phytotoxin assembly. The mech-
anisms of polyketide and peptide toxin biosynthesis in Pseudo-
monas exhibit unique features that expand the boundaries of
antimicrobial metabolite synthesis. These systems offer valu-
able insight into the ecological significance of toxin synthesis
and how they may be exploited in the quest to bioengineer new
pharmaceutical products.
The regulatory circuits which modulate phytotoxin synthesis
in P. syringae are poorly understood. Although some of the
signals for phytotoxin production have been defined, the mech-
anisms used for integration of these signals and the regulatory
cascades involved remain unclear. An especially intriguing
question is the potential relationship between phytotoxin syn-
thesis and the type III secretion system encoded by the hrp
gene cluster. The coordinated regulation of genes involved in
pathogenicity (hrp cluster) and virulence (phytotoxin produc-
tion) seems logical but has not been established.
The evolution of phytotoxin gene clusters remains a mystery.
The structural gene clusters for COR, syringomycin, and sy-
ringopeptin indicate biosynthetic relatedness to compounds
synthesized by nonribosomal, multifunctional enzymes. How-
ever, each phytotoxin gene cluster has distinctive features, sug-
gesting that evolutionary divergence from systems defined in
gram-positive bacteria has occurred. Furthermore, genes re-
lated to various transposases have been identified in the bor-
ders of phytotoxin gene clusters (270). Obviously, the potential
occurrence of phytotoxin gene clusters within pathogenicity
islands warrants investigation.
CONCLUSIONS
This review focuses on the five most intensively studied
phytotoxins of P. syringae, all of which contribute significantly
to bacterial virulence. COR functions partly as a mimic of
MeJA, a potent hormone synthesized by plants undergoing
biological stress. Syringomycin and syringopeptin form pores in
plasma membranes, a process that leads to electrolyte leakage.
Tabtoxin and phaseolotoxin are strongly antimicrobial and
function by inhibiting glutamine synthetase and OCTase, re-
spectively.
Genetic analysis has revealed the mechanisms responsible
for toxin biosynthesis. COR biosynthesis requires the cooper-
ation of PKSs and peptide synthetases for the CFA and CMA
moieties, respectively. Tabtoxin is derived from the lysine bio-
synthetic pathway, whereas peptide synthetases are required
for syringomycin, syringopeptin, and phaseolotoxin assembly.
Activation of toxin synthesis is controlled by diverse envi-
ronmental factors including plant signal molecules and tem-
perature. Genes involved in the regulation of phytotoxin syn-
thesis have been located within the COR and syringomycin
gene clusters; however, additional regulatory genes are re-
quired for the synthesis of these and other phytotoxins. Global
regulatory genes such as gacS modulate phytotoxin production
in certain pathovars, indicating the complexity of the regula-
tory circuits controlling phytotoxin synthesis.
The COR and syringomycin gene clusters have been inten-
sively characterized and show potential for constructing mod-
ified polyketides and peptides. Genetic reprogramming of pep-
tide and polyketide synthetases is feasible, and portions of the
COR and syringomycin gene clusters could be valuable re-
sources in developing new antimicrobial agents. Finally, char-
acterization of phytotoxin gene clusters has led to improved
methods of disease detection and diagnosis.
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